http://fasb.org/srt/2026#ChiefExecutiveOfficerMember NONE 00-0000000 Q1 false 0001827899 --12-31 0001827899 2026-01-01 2026-03-31 0001827899 2025-01-01 2025-03-31 0001827899 2025-12-31 0001827899 2026-03-31 0001827899 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2025-12-31 0001827899 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2026-03-31 0001827899 cptkw:PrivatePlacementWarrantsMember 2026-01-01 2026-03-31 0001827899 srt:MaximumMember cptkw:PublicWarrantsMember 2026-01-01 2026-03-31 0001827899 srt:MinimumMember cptkw:PublicWarrantsMember 2026-01-01 2026-03-31 0001827899 cptkw:PublicWarrantsMember 2026-01-01 2026-03-31 0001827899 us-gaap:CommonClassAMember us-gaap:WarrantMember 2026-03-31 0001827899 cptkw:PublicWarrantsMember 2026-03-31 0001827899 us-gaap:CommonClassAMember 2026-01-01 2026-03-31 0001827899 us-gaap:CommonClassBMember 2025-12-31 0001827899 us-gaap:CommonClassBMember 2026-03-31 0001827899 us-gaap:CommonClassBMember 2025-03-31 0001827899 cptkw:CommonClassASubjectToRedemptionMember 2025-12-31 0001827899 cptkw:CommonClassASubjectToRedemptionMember 2026-03-31 0001827899 us-gaap:CommonClassAMember 2025-03-31 0001827899 us-gaap:CommonClassAMember 2026-03-31 0001827899 cptkw:JettCapitalMember 2026-01-01 2026-03-31 0001827899 2025-06-03 0001827899 cptkw:LancasterMember cptkw:ConvertiblePromissoryNoteMember 2025-06-02 0001827899 us-gaap:RelatedPartyMember 2025-12-31 0001827899 us-gaap:RelatedPartyMember 2026-03-31 0001827899 cptkw:SponsorMember 2026-01-01 2026-03-31 0001827899 us-gaap:RelatedPartyMember 2026-01-01 2026-03-31 0001827899 cptkw:CIIGMember 2026-01-01 2026-03-31 0001827899 2026-02-10 0001827899 2025-03-28 2025-03-28 0001827899 cptkw:ConvertibleNoteMember 2023-05-31 2023-05-31 0001827899 srt:ChiefExecutiveOfficerMember us-gaap:WarrantMember 2021-11-30 2021-11-30 0001827899 srt:ChiefExecutiveOfficerMember 2021-11-30 2021-11-30 0001827899 us-gaap:RelatedPartyMember srt:ChiefExecutiveOfficerMember cptkw:ConvertibleNoteMember 2021-11-30 0001827899 cptkw:BusinessCombinationMember us-gaap:WarrantMember 2026-03-31 0001827899 cptkw:BusinessCombinationMember 2026-03-31 0001827899 us-gaap:CommonClassAMember srt:MaximumMember 2026-01-01 2026-03-31 0001827899 us-gaap:CommonClassAMember srt:MinimumMember 2026-01-01 2026-03-31 0001827899 us-gaap:CommonClassBMember cptkw:PrivatePlacementWarrantsMember 2023-01-17 2023-01-17 0001827899 us-gaap:CommonClassAMember cptkw:PrivatePlacementWarrantsMember 2023-01-17 2023-01-17 0001827899 us-gaap:CommonClassBMember cptkw:FounderShareMember 2023-01-17 2023-01-17 0001827899 cptkw:SponsorMember 2021-02-01 2021-02-28 0001827899 cptkw:FounderShareMember 2021-02-01 2021-02-28 0001827899 cptkw:FounderShareMember 2021-02-11 2021-02-11 0001827899 us-gaap:CommonClassBMember cptkw:FounderShareMember 2021-02-09 0001827899 us-gaap:CommonClassBMember 2021-02-09 2021-02-09 0001827899 us-gaap:CommonClassAMember cptkw:FounderShareMember cptkw:SponsorMember 2020-10-13 2020-10-13 0001827899 us-gaap:CommonClassBMember cptkw:FounderShareMember cptkw:SponsorMember 2020-10-13 2020-10-13 0001827899 us-gaap:CommonClassAMember cptkw:PrivatePlacementWarrantsMember 2026-03-31 0001827899 cptkw:PrivatePlacementWarrantsMember 2026-03-31 0001827899 us-gaap:IPOMember cptkw:PublicWarrantMember 2026-01-01 2026-03-31 0001827899 us-gaap:IPOMember us-gaap:CommonClassAMember cptkw:PublicWarrantMember 2026-03-31 0001827899 us-gaap:IPOMember us-gaap:CommonClassAMember 2026-01-01 2026-03-31 0001827899 us-gaap:IPOMember us-gaap:CommonClassAMember 2026-03-31 0001827899 us-gaap:IPOMember 2026-03-31 0001827899 us-gaap:IPOMember 2026-01-01 2026-03-31 0001827899 us-gaap:CommonClassBMember 2026-02-10 0001827899 us-gaap:CommonClassBMember 2026-01-01 2026-03-31 0001827899 us-gaap:CommonClassBMember us-gaap:WarrantMember us-gaap:InvestorMember 2026-03-09 0001827899 us-gaap:CommonClassBMember us-gaap:WarrantMember us-gaap:InvestorMember 2026-03-29 2026-03-29 0001827899 us-gaap:CommonClassBMember 2026-03-09 2026-03-09 0001827899 us-gaap:CommonClassBMember 2026-03-09 0001827899 us-gaap:CommonClassBMember cptkw:NonRedemptionAgreementsMember 2025-05-09 0001827899 us-gaap:CommonClassBMember cptkw:NonRedemptionAgreementsMember 2025-05-09 2025-05-09 0001827899 us-gaap:CommonClassAMember cptkw:NonRedemptionAgreementsMember 2025-05-09 0001827899 us-gaap:CommonClassAMember cptkw:NonRedemptionAgreementsMember 2025-05-09 2025-05-09 0001827899 us-gaap:PrivatePlacementMember 2026-03-31 0001827899 us-gaap:WarrantMember 2026-03-31 0001827899 cptkw:NonredeemableClassBMember 2025-01-01 2025-03-31 0001827899 cptkw:RedeemableClassAMember 2025-01-01 2025-03-31 0001827899 cptkw:NonredeemableClassBMember 2026-01-01 2026-03-31 0001827899 cptkw:RedeemableClassAMember 2026-01-01 2026-03-31 0001827899 us-gaap:CommonClassAMember us-gaap:WarrantMember 2021-02-11 0001827899 us-gaap:CommonClassAMember 2021-02-11 2021-02-11 0001827899 cptkw:OrdinarySharesSubjectToPossibleRedemptionMember 2026-03-31 0001827899 cptkw:OrdinarySharesSubjectToPossibleRedemptionMember 2026-01-01 2026-03-31 0001827899 cptkw:OrdinarySharesSubjectToPossibleRedemptionMember 2025-12-31 0001827899 cptkw:OrdinarySharesSubjectToPossibleRedemptionMember 2025-01-01 2025-12-31 0001827899 cptkw:OrdinarySharesSubjectToPossibleRedemptionMember 2024-12-31 0001827899 cptkw:NonRedemptionAgreementsMember 2026-03-09 0001827899 us-gaap:CommonClassBMember cptkw:NonRedemptionAgreementsMember 2026-03-09 2026-03-09 0001827899 us-gaap:CommonClassAMember 2026-03-09 0001827899 us-gaap:CommonClassAMember cptkw:NonRedemptionAgreementsMember 2026-03-09 0001827899 us-gaap:CommonClassAMember 2026-03-09 2026-03-09 0001827899 cptkw:NonRedemptionAgreementsMember 2025-05-09 0001827899 us-gaap:CommonClassAMember 2025-05-09 0001827899 us-gaap:CommonClassAMember cptkw:NonRedemptionAgreementsMember 2024-08-09 0001827899 us-gaap:CommonClassAMember 2025-05-09 2025-05-09 0001827899 2021-02-11 2021-02-11 0001827899 us-gaap:IPOMember 2021-02-11 2021-02-11 0001827899 2025-03-31 0001827899 2024-12-31 0001827899 us-gaap:RetainedEarningsMember 2025-03-31 0001827899 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0001827899 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2025-03-31 0001827899 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0001827899 us-gaap:RetainedEarningsMember 2024-12-31 0001827899 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001827899 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2024-12-31 0001827899 us-gaap:RetainedEarningsMember 2026-03-31 0001827899 us-gaap:AdditionalPaidInCapitalMember 2026-03-31 0001827899 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2026-03-31 0001827899 us-gaap:RetainedEarningsMember 2026-01-01 2026-03-31 0001827899 us-gaap:AdditionalPaidInCapitalMember 2026-01-01 2026-03-31 0001827899 us-gaap:RetainedEarningsMember 2025-12-31 0001827899 us-gaap:AdditionalPaidInCapitalMember 2025-12-31 0001827899 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2025-12-31 0001827899 cptkw:NonRedeemableSharesMember 2025-01-01 2025-03-31 0001827899 cptkw:NonRedeemableSharesMember 2026-01-01 2026-03-31 0001827899 cptkw:RedeemableSharesMember 2025-01-01 2025-03-31 0001827899 cptkw:RedeemableSharesMember 2026-01-01 2026-03-31 0001827899 us-gaap:CommonClassAMember 2025-12-31 0001827899 us-gaap:CommonClassBMember 2026-05-18 0001827899 us-gaap:CommonClassAMember 2026-05-18 0001827899 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2026-01-01 2026-03-31 0001827899 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2025-12-31 0001827899 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2025-12-31 0001827899 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2026-03-31 0001827899 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2026-03-31 0001827899 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member cptkw:PublicWarrantsMember 2025-12-31 0001827899 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member cptkw:PublicWarrantsMember 2025-12-31 0001827899 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member cptkw:PublicWarrantsMember 2025-12-31 0001827899 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member cptkw:PrivateWarrantsMember 2025-12-31 0001827899 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member cptkw:PrivateWarrantsMember 2025-12-31 0001827899 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member cptkw:PrivateWarrantsMember 2025-12-31 0001827899 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member cptkw:PublicWarrantsMember 2026-03-31 0001827899 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member cptkw:PublicWarrantsMember 2026-03-31 0001827899 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member cptkw:PublicWarrantsMember 2026-03-31 0001827899 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member cptkw:PrivateWarrantsMember 2026-03-31 0001827899 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member cptkw:PrivateWarrantsMember 2026-03-31 0001827899 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member cptkw:PrivateWarrantsMember 2026-03-31 0001827899 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2025-01-01 2025-03-31 0001827899 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-03-31 iso4217:USD cptkw:Segments xbrli:pure iso4217:USD xbrli:shares xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended ~~September~~March 3031, ~~2025~~2026

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

CROWN PROPTECH ACQUISITIONS

(Exact name of registrant as specified in its charter)

Cayman Islands		001-40017		N/A
(State or other jurisdiction of incorporation or organization)		(Commission File Number)		(I.R.S. Employer Identification Number)

40 West 57th Street, 29th Floor New York, NY		10019
(Address of principal executive offices)		(Zip Code)

+1(212) 796-4796

(Registrant’s telephone number, including area code)

Not applicable

(Former name or former address, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50		CPTKW		N/A

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☐ No ☒

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T(§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☐ No ☒

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated filer	☒	Emerging growth company	☒
		Smaller reporting company	☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☒ No ☐

As of ~~December~~May 2318, ~~2025~~2026, ~~491~~483,~~806~~822 Class A ordinary shares, par value $0.0001, and 6,900,000 Class B ordinary shares, par value $0.0001, were issued and outstanding.

CROWN PROPTECH ACQUISITIONS

Quarterly Report on Form 10-Q

Table of Contents

		Page No.
PART I. FINANCIAL INFORMATION
Item 1.	Financial Statements	1
	Condensed Balance Sheets as of September 30, 2025 (unaudited) and December 31, 2024	1
	Condensed Balance Sheets as of March 31, 2026 (unaudited) and December 31, 2025	1
	Unaudited Condensed Statements of Operations for the Three and Nine Months Ended September 30, 2025 and 2024	2
	Unaudited Condensed Statements of Operations for the Three Months Ended March 31, 2026 and 2025	2
	Unaudited Condensed Statements of Changes in Shareholders’ Deficit for the Three and Nine Months Ended September 30, 2025 and 2024	3
	Unaudited Condensed Statements of Changes in Shareholders’ Deficit for the Three Months Ended March 31, 2026 and 2025	3
	Unaudited Condensed Statements of Cash Flows for the Nine Months Ended September 30, 2025 and 2024	4
	Unaudited Condensed Statements of Cash Flows for the Three Months Ended March 31, 2026 and 2025	4
	Notes to Unaudited Condensed Financial Statements	5
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	2220
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	3027
Item 4.	Controls and Procedures	3027
PART II. OTHER INFORMATION
Item 1.	Legal Proceedings	3128
Item 1A.	Risk Factors	3128
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	3128
Item 3.	Defaults Upon Senior Securities	3128
Item 4.	Mine Safety Disclosures	3128
Item 5.	Other Information	3128
Item 6.	Exhibits	3229
SIGNATURES		3330

PART I—FINANCIAL INFORMATION

Item 1. Financial Statements.

CROWN PROPTECH ACQUISITIONS

CONDENSED BALANCE SHEETS

	September 30, 2025			December 31, 2024
	March 31, 2026			December 31, 2025
	(Unaudited)
Assets
Current assets:
Cash	$	425		$	425
Prepaid expenses		8238,~~280~~179			~~1,594~~992
Total current assets		8238,~~705~~604			21,~~019~~417
Investments held in Trust Account		5,~~732~~744,~~823~~230			5,~~804~~788,~~083~~250
Total assets	$	5,~~815~~782,~~528~~834		$	5,~~806~~789,~~102~~667
Liabilities, Class A ordinary shares subject to possible redemption and Shareholders’ Deficit
Current liabilities:
Accounts payable and accrued expenses	$	34,~~432~~183,~~103~~231		$	13,~~790~~705,~~528~~873
Due to related parties		1,~~567~~592,~~897~~586			1,~~189~~592,~~077~~586
Total current liabilities		5,000,000			2,979,605
Total liabilities		5,775,817			5,298,459
Warrant liabilities		—			14
Total liabilities		5,000,000			2,979,619
Commitments
Class A ordinary shares subject to possible redemption, 491,806 and 513,613 shares at a redemption value of $11.66 and $11.30 as of September 30, 2025 and December 31, 2024, respectively		5,732,823			5,804,083
Class A ordinary shares subject to possible redemption, 483,822 and 491,806 shares at a redemption value of $11.87 and $11.77 as of March 31, 2026 and December 31, 2025, respectively		5,744,230			5,788,250
Shareholders’ deficit:
Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding		—			—
Class A ordinary shares, $0.0001 par value; 200,000,000 shares authorized; no shares issued or outstanding, excluding 491,806 and 513,613 shares subject to possible redemption as of September 30, 2025 and December 31, 2024, respectively		—			—
Class A ordinary shares, $0.0001 par value; 200,000,000 shares authorized; no shares issued or outstanding, excluding 483,822 and 491,806 shares subject to possible redemption as of as of March 31, 2026 and December 31, 2025, respectively		—			—
Class B ordinary shares, $0.0001 par value; 20,000,000 shares authorized; 6,900,000 shares issued and outstanding		690			690
Additional paid-in capital		1213,~~406~~631,~~701~~656			12,~~063~~991,~~607~~960
Accumulated deficit		(1719,~~324~~369,~~686~~559	)		(1518,~~041~~289,~~897~~692	)
Total shareholders’ deficit		(45,~~917~~737,~~295~~213	)		(25,~~977~~297,~~600~~042	)
Total liabilities, class A ordinary shares subject to possible redemption, and shareholders’ deficit	$	5,~~815~~782,~~528~~834		$	5,~~806~~789,~~102~~667

The accompanying notes are an integral part of these unaudited condensed financial statements.

CROWN PROPTECH ACQUISITIONS

CONDENSED STATEMENTS OF OPERATIONS

(UNAUDITED)

	For the Three Months Ended September 30,						For the Nine Months Ended September 30,
	For the Three Months Ended March 31,
	2025			2024			2025			2024
	2026			2025
Operating costs	$	~~281~~1,~~409~~069,505		$	~~260~~772,~~603~~793		$	~~2,059,665~~		$	~~688,859~~
Loss from operations		(~~281~~1,~~409~~069,505	)		(~~260~~772,~~603~~793	)		~~(2,059,665~~	)		~~(688,859~~	)
Other income (expense):
Other (expense) income:
Trust dividend income		58,689			174,717			178,797			880,933
Loan Extension Agreement expense		(10,362	)		—
Non-redemption agreement expense		—			(75,341	)		(223,138	)		(451,322	)
Trust dividend income		50,560			60,666
Change in fair value of warrant liabilities		35,533			—			14			—
Total other income, net		40,198			60,666
Settlement of payables		—			—			—			—
Net loss	$	(1,029,307	)	$	(712,127	)
Total other income (expense), net		94,222			99,376			(44,327	)		429,611
Weighted average redeemable shares outstanding		489,766			513,613
Net loss	$	(187,187	)	$	(161,227	)	$	(2,103,992	)	$	(259,248	)
Basic and diluted net loss per redeemable share	$	(0.14	)	$	(0.10	)
Weighted average redeemable shares outstanding		491,806			1,224,799			502,031			2,047,258
Weighted average non-redeemable shares outstanding		6,900,000			6,900,000
Basic and diluted net loss per redeemable share	$	(0.03	)	$	(0.02	)	$	(0.28	)	$	(0.03	)
Basic and diluted net loss per non-redeemable share	$	(0.14	)	$	(0.10	)
Weighted average non-redeemable shares outstanding		6,900,000			6,900,000			6,900,000			6,900,000
Basic and diluted net loss per non-redeemable ordinary share	$	(0.03	)	$	(0.02	)	$	(0.28	)	$	(0.03	)

The accompanying notes are an integral part of these unaudited condensed financial statements.

CROWN PROPTECH ACQUISITIONS

CONDENSED STATEMENTS OF CHANGES IN SHAREHOLDERS’ DEFICIT

(UNAUDITED)

FOR THE THREE ~~AND NINE~~ MONTHS ENDED ~~SEPTEMBER 30~~MARCH 31, ~~2025~~2026

	Ordinary Shares				Additional					Total
	Class B				Paid-in		Accumulated			Shareholders’
	Shares		Amount		Capital		Deficit			Deficit
Balance as of December 31, 2024		6,900,000	$	690	$	12,063,607	$	(15,041,897	)	$	(2,977,600	)
Balance as of December 31, 2025		6,900,000	$	690	$	12,991,960	$	(18,289,692	)	$	(5,297,042	)
Remeasurement of ordinary shares subject to redemption value		—		—		—		(60,666	)		(60,666	)
Capital contribution from Sponsors		—		—		629,334		—			629,334
Net loss		—		—		—		(712,127	)		(712,127	)
Equity contribution from Loan Extension Agreement		—		—		10,362		—			10,362
Balance as of March 31, 2025		6,900,000		690		12,063,607		(15,814,690	)		(3,750,393	)
Remeasurement of redeemable ordinary shares to redemption value		—		—		—		(50,560	)		(50,560	)
Remeasurement of ordinary shares subject to redemption value		—		—		—		(59,442	)		(59,442	)
Net loss		—		—		—		(1,029,307	)		(1,029,307	)
Capital contribution from Sponsor		—		—		223,138		—			223,138
Balance as of March 31, 2026		6,900,000	$	690	$	13,631,656	$	(19,369,559	)	$	(5,737,213	)
Net loss		—		—		—		(1,204,678	)		(1,204,678	)
Balance as of June 30, 2025		6,900,000	$	690	$	12,286,745	$	(17,078,810	)	$	(4,791,375	)
Remeasurement of ordinary shares subject to redemption value		—		—		—		(58,689	)		(58,689	)
Capital contribution from Sponsor		—		—		119,956		—			119,956
Net loss		—		—		—		(187,187	)		(187,187	)
Balance as of September 30, 2025		6,900,000	$	690	$	12,406,701	$	(17,324,686	)	$	(4,917,295	)

FOR THE THREE ~~AND NINE~~ MONTHS ENDED ~~SEPTEMBER~~MARCH 3031, ~~2024~~2025

	Ordinary Shares				Additional					Total
	Class B				Paid-in		Accumulated			Shareholders’
	Shares		Amount		Capital		Deficit			Deficit
Balance as of December 31, 2023		6,900,000	$	690	$	11,612,285	$	(13,890,094	)	$	(2,277,119	)
Balance as of December 31, 2024		6,900,000	$	690	$	12,063,607	$	(15,041,897	)	$	(2,977,600	)
Remeasurement of ordinary shares subject to redemption value		—		—		—		(424,985	)		(424,985	)
Remeasurement of redeemable ordinary shares to redemption value		—		—		—		(60,666	)		(60,666	)
Capital contribution from Sponsor		—		—		375,981		—			375,981
Net loss		—		—		—		(712,127	)		(712,127	)
Net loss		—		—		—		(333,546	)		(333,546	)
Balance as of March 31, 2025		6,900,000	$	690	$	12,063,607	$	(15,814,690	)	$	(3,750,393	)
Balance as of March 31, 2024		6,900,000		690		11,988,266		(14,648,625	)		(2,659,669	)
Remeasurement of ordinary shares subject to redemption value		—		—		—		(281,231	)		(281,231	)
Net income		—		—		—		235,525			235,525
Balance as of June 30, 2024		6,900,000		690		11,988,266		(14,694,331	)		(2,705,375	)
Remeasurement of ordinary shares subject to redemption value		—		—		—		(174,717	)		(174,717	)
Capital contribution from Sponsor		—		—		75,341		—			75,341
Net loss		—		—		—		(161,227	)		(161,227	)
Balance as of September 30, 2024		6,900,000	$	690	$	12,063,607	$	(15,030,275	)	$	(2,965,978	)

The accompanying notes are an integral part of these unaudited condensed financial statements.

CROWN PROPTECH ACQUISITIONS

CONDENSED STATEMENTS OF CASH FLOWS

(UNAUDITED)

	For the Nine Months Ended September 30,
	For the Three Months Ended March 31,
	2025			2024
	2026			2025
Cash Flows from Operating Activities:
Net loss	$	(21,~~103~~029,~~992~~307	)	$	(~~259~~712,~~248~~127	)
Adjustments to reconcile net loss to net cash used in operating activities:
Change in fair value of warrant liabilities		(14	)		—
Loan Extension Agreement expense		10,362			—
Non-redemption agreement expense		223,138			451,322
Trust dividend income		(50,560	)		(60,666	)
Trust dividend income		(178,797	)		(880,933	)
Changes in current assets and current liabilities:
Prepaid expenses		(8037,~~686~~187	)		(14,~~578~~100	)
Accounts payable and accrued expenses		1477,~~641,575~~358			~~426~~690,~~954~~751
Net cash used in operating activities		(~~498~~629,~~776~~334	)		(~~263~~86,~~483~~142	)
Cash Flows from Investing Activities:
Cash withdrawn from Trust Account in connection with redemption		~~250~~94,~~057~~580			~~40,209,102~~—
Net cash provided by investing activities		~~250~~94,~~057~~580			~~40,209,102~~—
Cash Flows from Financing Activities:
Proceeds from promissory note to related party		~~378~~629,~~820~~334			~~263~~86,~~256~~142
Capital contribution from the Sponsor		119,956			—
Redemption of Class A ordinary share subject to possible redemption		(94,580	)		—
Redemption of Class A ordinary share subject to possible redemption		(250,057	)		(40,209,102	)
Net cash provided by financing activities		534,754			86,142
Net cash provided by (used in) financing activities		248,719			(39,945,846	)
Net Change in Cash		—			—
Net Change in Cash		—			(227	)
Cash—Beginning of period		425			425
Cash—Beginning of period		425			652
Cash—Ending of period	$	425		$	425
Supplemental Disclosure of Non-cash Financing Activities:
Remeasurement of Class A ordinary shares subject to possible redemption	$	~~178~~50,~~797~~560		$	~~880~~60,~~933~~666

The accompanying notes are an integral part of these unaudited condensed financial statements.

CROWN PROPTECH ACQUISITIONS

NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS

~~September 30~~March 31, ~~2025~~2026

Note 1 — Organization and Business Operations

Organization and General

Crown PropTech Acquisitions (the “Company” or “Crown”) was incorporated in the Cayman Islands on September 24, 2020. The Company was formed for the purpose of entering into a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar Business Combination with one or more businesses (a “Business Combination”). The Company is not limited to a particular industry or geographic region for purposes of consummating a Business Combination. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.

As of ~~September~~March 3031, ~~2025~~2026, the Company had not yet commenced any operations. All activity through ~~September~~March 3031, ~~2025~~2026, relates to the Company’s formation and the Initial Public Offering (“IPO”) described below, and since the closing of the IPO, the search for a prospective initial Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income on cash and cash equivalents from the proceeds derived from the IPO.

The Company’s sponsors are Crown PropTech Sponsor, LLC (“Crown PropTech Sponsor”), a Delaware limited liability company and CIIG Management III LLC (“CIIG”), a Delaware limited liability company, (each, a “Sponsor” and together, the “Sponsors”).

Change in Management

On February 15, 2024, Gavin Cuneo notified the Company of his decision to resign as the co-chief executive officer of the Company, effective immediately.

Michael Minnick, the Company’s Chief Executive Officer, assumed the role of principal financial and accounting officer of the Company effective upon Mr. Cuneo’s resignation. Mr. Minnick has served as the Company’s Co-Chief Executive Officer since January 2023.

Notice of Delisting

On February 12, 2024, the New York Stock Exchange (the “NYSE”) determined that the Company was not in compliance with Section 802.01B and 102.06e of the NYSE Listed Company Manual (the “LCM”) because the Company failed to consummate a Business Combination within the shorter of (i) the time period specified by its constitutive documents or by contract or (ii) three years. As such, the NYSE had determined to commence proceedings to delist from the NYSE the Company’s Class A ordinary shares and Units.

Trading of the Company’s securities was suspended on February 12, 2024. The NYSE applied to the SEC to delist the Company’s securities upon completion of all applicable procedures. The Company did not appeal the staff’s determination and, accordingly, the Company’s securities were delisted from the NYSE.

Trust Account

Following the closing of the IPO on February 11, 2021, an amount of $276,000,000 from the net proceeds of the sale of the Units in the IPO and the sale of the Private Placement Warrants was placed in a trust account (“Trust Account”) which is invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940 (the “Investment Company Act”), with a maturity of 185 days or less or in any open-ended investment company that holds itself out as a money market fund meeting the conditions of Rule 2a-7 of the Investment Company Act, as determined by the Company. Except with respect to interest earned on the funds held in the Trust Account that may be released to the Company to pay its tax obligations, if any, the proceeds from the IPO and the sale of the private placement units will not be released from the Trust Account until the earliest of (a) the completion of the Company’s initial Business Combination, (b) the redemption of any public shares properly submitted in connection with a shareholder vote to amend the Company’s amended and restated certificate of incorporation, and (c) the redemption of the Company’s public shares if the Company is unable to complete the initial Business Combination, subject to applicable law. The proceeds deposited in the Trust Account could become subject to the claims of the Company’s creditors, if any, which could have priority over the claims of the Company’s public shareholders.

As discussed below, the Company’s shareholders have agreed to extend the date by which the Company must consummate an initial Business Combination from May 11, 2025 to March 11, 2026 and on March 9, 2026 the Company’s shareholders extended the date by which the Company must consummate an initial Business Combination from March 11, 2026 to March 11, 2027.

Initial Business Combination

The Company’s management has broad discretion with respect to the specific application of the net proceeds of the IPO, although substantially all of the net proceeds are intended to be generally applied toward consummating a Business Combination.

The Company’s Business Combination must be with one or more target businesses that together have a fair market value equal to at least 80% of the balance in the Trust Account (as defined below) (net of taxes payable) at the time of the signing an agreement to enter into a Business Combination. However, the Company will only complete a Business Combination if the post-Business Combination company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act. There is no assurance that the Company will be able to successfully effect a Business Combination.

The Company will provide its public shareholders with the opportunity to redeem all or a portion of their public shares upon the completion of the initial Business Combination either (i) in connection with a shareholder meeting called to approve the initial Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a proposed initial Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The shareholders will be entitled to redeem their shares for a pro rata portion of the amount then on deposit in the Trust Account (initially $10.00 per share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations, if any).

The Class A ordinary shares subject to redemption are recorded at a redemption value and classified as temporary equity upon the completion of the IPO, in accordance with Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” In such case, the Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 either immediately prior to or upon consummation of a Business Combination and, if the Company seeks shareholder approval, a majority of the issued and outstanding shares voted are voted in favor of the Business Combination.

The Company has until March 11, ~~2026~~2027 to consummate a Business Combination (the “Combination Period”). However, if the Company is unable to complete a Business Combination within the Combination Period, the Company will redeem 100% of the outstanding public shares for a pro rata portion of the funds held in the Trust Account, equal to the aggregate amount then on deposit in the trust account including interest earned on the funds held in the trust account and not previously released to the Company, divided by the number of then outstanding public shares, subject to applicable law and as further described in the registration statement, and then seek to dissolve and liquidate.

The Company’s Sponsors, officers and directors have agreed to (i) waive their redemption rights with respect to their Founder Shares, private placement shares and public shares in connection with the completion of the initial Business Combination, (ii) waive their redemption rights with respect to their Founder Shares and public shares in connection with a shareholder vote to approve an amendment to the Company’s amended and restated certificate of incorporation, and (iii) waive their rights to liquidating distributions from the Trust Account with respect to their Founder Shares and private placement shares if the Company fails to complete the initial Business Combination within the Combination Period.

In the event of a liquidation of the Trust Account upon the failure of the Company to consummate its initial Business Combination by March 11, ~~2026~~2027, Crown PropTech Sponsor (but not CIIG) has agreed that it will indemnify the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or similar agreement or Business Combination agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.00 per public share and (ii) the actual amount per public share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.00 per share due to reductions in the value of the trust assets, less taxes payable, if any, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to the monies held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company’s indemnity of the underwriters of the IPO against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). However, the Company has not asked Crown PropTech Sponsor to reserve for such indemnification obligations, nor has the Company independently verified whether Crown PropTech Sponsor has sufficient funds to satisfy its indemnity obligations and believe that Crown PropTech Sponsor’s only assets are securities of the Company. Therefore, the Company cannot assure that Crown PropTech Sponsor would be able to satisfy those obligations.

Business Combination Agreement

On July 2, 2025, the Company (“SPAC”), (ii) Mkango (Cayman) Limited, an exempted company limited by shares incorporated under the laws of the Cayman Islands and a direct wholly owned Subsidiary of ~~Lancaster~~MKAR (as defined below) (“Merger Sub”), (iii) Mkango Rare Earths Limited (f/k/a Lancaster Exploration Limited), a company organized under the laws of the British Virgin Islands (“~~Lancaster~~MKAR”, and from and after the Closing, “PubCo”), and a direct, wholly owned subsidiary of Mkango Resources Ltd., a company organized under the laws of British Columbia, Canada (the “Selling Shareholder”), (iv) Mkango Polska s.p. Z.o.o., a company organized under the laws of Poland and a direct, wholly owned subsidiary of Selling Shareholder (“MKA Poland”), (v) Mkango ServiceCo UK Limited, a company organized under the laws of England and a direct, wholly owned subsidiary of Selling Shareholder (“Mkango ServiceCo”), and (vi) MKA Exploration Ltd., a company organized under the laws of the British Virgin Islands and a direct, wholly owned subsidiary of Selling Shareholder (“MKA BVI”, and together with ~~Lancaster~~MKAR, MKA Poland and Mkango ServiceCo, the “Companies”) entered into a business combination agreement (the “Business Combination Agreement”). Capitalized terms used herein but not defined shall have the meanings as set forth in the Business Combination Agreement.

Pursuant to the Business Combination Agreement, the parties thereto will enter into a business combination transaction by which, among other things, Merger Sub will be merged with and into SPAC, with SPAC being the surviving entity of the Merger and becoming a wholly-owned subsidiary of PubCo. Concurrently therewith, PubCo will become a publicly traded company, expected to operate under the name “Mkango Rare Earths Limited,” and its ordinary shares are expected to trade on Nasdaq.

The proposed Merger and the other transactions contemplated by the Business Combination Agreement (collectively, the “Transactions”) are expected to be consummated after the required approval by the shareholders of SPAC and the satisfaction of certain other conditions as described in the Business Combination Agreement in the Company’s Form 8-K filed with the SEC on July 3, 2025.

Amendment No. 1 to Business Combination Agreement

On February 13, 2026, the Company and MKAR entered into Amendment No. 1 to the Business Combination Agreement (“Amendment No. 1”). Amendment No. 1, among other things, amends the pre-closing internal corporate reorganization to establish the ownership structure so that MKAR will own the assets and operations associated with the rare earth project at Songwe Hill in Malawi and the proposed separation plant to be constructed in Pulawy, Poland and extends the Outside Date from March 11, 2026 to September 30, 2026, with an automatic extension to December 31, 2026 if the U.S. Securities and Exchange Commission (the “SEC”) has not declared the Proxy/Registration Statement effective by August 14, 2026.

Shareholder Meetings

February 9, 2024

On February 9, 2024, the Company’s shareholders approved an amendment to amend and restate the Company’s Second Amended and Restated Memorandum and Articles of Association to extend the date by which the Company must consummate an initial Business Combination from February 11, 2024 to August 11, 2024 (the “February 2024 Extension Proposal”).

Associated with the February 9, 2024 Extraordinary General Meeting, the Company and CIIG entered into the February 2024 Non-Redemption Agreements with certain investors pursuant to which, if such investors do not redeem (or validly rescind any redemption requests on) their Class A ordinary shares of the Company (the “February 2024 Non-Redeemed Shares”) in connection with the February 9, 2024 Extraordinary General Meeting, CIIG will agree to transfer to such investors Class B ordinary shares held by CIIG immediately following the consummation of an initial Business Combination if they continue to hold such February 2024 Non-Redeemed Shares through the February 9, 2024 Extraordinary General Meeting.

The February 9, 2024 Non-Redemption Agreements provide for the assignment of up to 464,414 Class B ordinary shares, par value $0.0001 per share, held by CIIG to the investors in exchange for such Investors agreeing to hold and not redeem certain public shares at the February 9, 2024 Extraordinary General Meeting.

In connection with the vote to approve the February 9, 2024 Extension Proposal, shareholders holding an aggregate of 2,195,847 shares of the Company’s Class A ordinary shares exercised their right to redeem their shares for a pro rata portion of the funds in the Trust Account. As a result, $23,724,846 (approximately $10.80 per share) was withdrawn from the Trust Account to redeem such shares. Following the redemptions, there were 2,000,638 Class A ordinary shares issued and outstanding.

August 9, 2024

On August 9, 2024, the Company’s shareholders approved an amendment to amend and restate the Company’s Third Amended and Restated Memorandum and Articles of Association to extend the date by which the Company must consummate an initial Business Combination from August 11, 2024 to May 11, 2025 (the “August 2024 Extension Proposal”).

In connection with the vote to approve the August 2024 Extension Proposal, shareholders holding an aggregate of 1,487,025 shares of the Company’s Class A ordinary shares exercised their right to redeem their shares for a pro rata portion of the funds in the Trust Account (as defined below). As a result, $16,484,256 (approximately $11.09 per share) was withdrawn from the Trust Account (described below) to redeem such shares. Following the redemptions, there were 513,613 Class A ordinary shares issued and outstanding.

Associated with the August 9, 2024 Extraordinary General Meeting, the Company and CIIG entered into non-redemption agreements (the “August 2024 Non-Redemption Agreements”) with certain investors pursuant to which, if such investors do not redeem (or validly rescind any redemption requests on) their Class A ordinary shares of the Company (the “August 2024 Non-Redeemed Shares”) in connection with the August 9, 2024 Extraordinary General Meeting, CIIG will agree to transfer to such investors Class B ordinary shares held by CIIG immediately following the consummation of an initial Business Combination if they continue to hold such August 2024 Non-Redeemed Shares through the August 9, 2024 Extraordinary General Meeting.

The August 2024 Non-Redemption Agreements provide for the assignment of economic interest of an aggregate of 115,287 Class B ordinary shares held by CIIG to the Non-Redeeming Investors in exchange for such Non-Redeeming Investors agreeing to hold and not redeem an aggregate of 461,146 Class A ordinary shares at the August 9, 2024 Extraordinary General Meeting.

May 9, 2025

On May 9, 2025, the Company’s shareholders approved an amendment to amend and restate the Company’s Fourth Amended and Restated Memorandum and Articles of Association to extend the date by which the Company must consummate an initial Business Combination from May 11, 2025 to March 11, 2026 (the “May 2025 Extension Proposal”).

In connection with the vote to approve the May 2025 Extension Proposal, shareholders holding an aggregate of 21,807 shares of the Company’s Class A ordinary shares exercised their right to redeem their shares for a pro rata portion of the funds in the Trust Account (as defined below). As a result approximately, $0.25 million (approximately $11.47 per share) was withdrawn from the Trust Account (described below) to redeem such shares. Following the redemptions, there were 491,806 Class A ordinary shares issued and outstanding.

Associated with the May 9, 2025 Extraordinary General Meeting, the Company and CIIG entered into non-redemption agreements (the “May 2025 Non-Redemption Agreements”) with certain investors pursuant to which, if such investors do not redeem (or validly rescind any redemption requests on) their Class A ordinary shares of the Company (the “May 2025 Non-Redeemed Shares”) in connection with the May 9, 2025 Extraordinary General Meeting, CIIG will agree to transfer to such investors Class B ordinary shares held by CIIG immediately following the consummation of an initial Business Combination if they continue to hold such May 2025 Non-Redeemed Shares through the May 9, 2025 Extraordinary General Meeting.

The May 2025 Non-Redemption Agreements provided for the assignment of up 115,287 Class B ordinary shares, par value $0.0001 per share, held by CIIG to the investors in exchange for such Investors agreeing to hold and not redeem certain public shares at the May 9, 2025 Extraordinary General Meeting.

March 9, 2026

On March 9, 2026, the Company’s shareholders approved an amendment to amend and restate the Company’s Fifth Amended and Restated Memorandum and Articles of Association to extend the date by which the Company must consummate an initial Business Combination from March 11, 2026 to March 11, 2027 (the “March 2026 Extension Proposal”).

In connection with the vote to approve the March 2026 Extension Proposal, shareholders holding an aggregate of 7,984 shares of the Company’s Class A ordinary shares exercised their right to redeem their shares for a pro rata portion of the funds in the Trust Account (as defined below). As a result, approximately $0.09 million (approximately $11.84 per share) was withdrawn from the Trust Account (described below) to redeem such shares. Following the redemptions, there were 483,822 Class A ordinary shares issued and outstanding.

In March 2026 the Company and CIIG entered into non-redemption agreements (the “March 2026 Non-Redemption Agreements”) with certain investors pursuant to which, if such investors do not redeem (or validly rescind any redemption requests on) their Class A ordinary shares of the Company (the “March 2026 Non-Redeemed Shares”) in connection with the March 9, 2026 Extraordinary General Meeting, CIIG will assign one Class B ordinary share, par value $0.0001 per share for each 40 public shares not redeemed, accruing monthly beginning April 11, 2026 until the completion of the initial Business Combination, held by CIIG to the investors in exchange for such investors agreeing to hold and not redeem certain public shares at the March 9, 2026 Extraordinary General Meeting.

The March 2026 Non-Redemption Agreements provided for the assignment of 11,529 Class B ordinary shares, par value $0.0001 per share, held by CIIG to the investors, accruing monthly beginning April 11, 2026 until the completion of the initial Business Combination, in exchange for such Investors agreeing to hold and not redeem certain public shares at the March 9, 2026 Extraordinary General Meeting.

Liquidity, Capital Resources and Going Concern

As of ~~September~~March 3031, ~~2025~~2026, the Company had cash outside the Trust Account of $425 available for working capital needs and working capital deficit of $45,~~917~~737,~~295~~213. All remaining cash held in the Trust Account is generally unavailable for the Company’s use, prior to an initial Business Combination, and is restricted for use either in a Business Combination or to redeem Class A ordinary shares. ~~As of September 30, 2025, none of the amount in the Trust Account was available to be withdrawn as described above.~~

Through ~~September~~March 3031, ~~2025~~2026, the Company’s liquidity needs were satisfied through receipt of $25,000 from the sale of the Founder Shares, the remaining net proceeds from the IPO, the sale of Private Placement Warrants, the Promissory Note (as defined below), the Working Capital Loan (as defined below) and capital contributions from the Sponsors of $~~793~~2,~~374~~007,967.

The Company has incurred and expects to continue to incur significant costs in pursuit of its financing and acquisition plans. The Company lacks the financial resources it needs to sustain operations for a reasonable period of time, which is considered to be one year from the issuance date of the unaudited condensed financial statements are issued. Although no formal agreement exists, the Sponsors are committed to extend loans as needed (see Note 5).

Accordingly, the Company may not be able to obtain additional financing. If the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could include, but not limited to, curtailing operations, suspending the pursuit of a potential merger target, and reducing overhead expenses. The Company cannot provide any assurance that new financing will be available to in on commercially acceptable terms, if at all, or that its plans to consummate an initial Business Combination will be successful.

In connection with the Company’s assessment of going concern considerations in accordance with ASC 205-40, “Presentation of Financial Statements-Going Concern,” management has determined that the above liquidity issues and the mandatory liquidation and subsequent dissolution, should the Company be unable to complete a Business Combination, raises substantial doubt about the Company’s ability to continue as a going concern. The Company has until March 11, ~~2026~~2027, or by the end of any extension to the Combination Period, to consummate a Business Combination. These conditions raise substantial doubt about the Company’s ability to continue as a going concern for a period of time within one year from the date that the unaudited condensed financial statements are issued. If a Business Combination is not consummated by this date, there will be a mandatory liquidation and subsequent dissolution. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after March 11, ~~2026~~2027.

Risks and Uncertainties

The United States and global markets are experiencing volatility and disruption following the geopolitical instability resulting from the ongoing Russia-Ukraine conflict and the escalation of ~~conflict~~conflicts in the Middle East and Southwest Asia. In response to the ongoing Russia-Ukraine conflict, the North Atlantic Treaty Organization (“NATO”) deployed additional military forces to eastern Europe, and the United States, the United Kingdom, the European Union and other countries have announced various sanctions and restrictive actions against Russia, Belarus and related individuals and entities, including the removal of certain financial institutions from the Society for Worldwide Interbank Financial Telecommunication (SWIFT) payment system. Certain countries, including the United States, have also provided and may continue to provide military aid or other assistance to Ukraine and to Israel, or have undertaken or will undertake military strikes in Southwest Asia, increasing geopolitical tensions among a number of nations. The invasion of Ukraine by Russia and the escalation of conflict in the Middle East and Southwest Asia and the resulting measures that have been taken, and could be taken in the future, by NATO, the United States, the United Kingdom, the European Union, Israel and its neighboring states and other countries have created global security concerns that could have a lasting impact on regional and global economies. Although the length and impact of the ongoing conflicts are highly unpredictable, they could lead to market disruptions, including significant volatility in commodity prices, credit and capital markets, as well as supply chain interruptions and increased cyber-attacks against U.S. companies. Additionally, any resulting sanctions could adversely affect the global economy and financial markets and lead to instability and lack of liquidity in capital markets. Any of the above-mentioned factors, or any other negative impact on the global economy, capital markets or other geopolitical conditions resulting from the Russian invasion of Ukraine, the escalation of conflict in the Middle East and Southwest Asia and subsequent sanctions or related actions, could adversely affect the Company’s search for an initial Business Combination and any target business with which the Company may ultimately consummate an initial Business Combination.

9Recent changes in international trade policies, tariffs and macroeconomic conditions have created and are expected to create global economic consequences. The specific impact on the Company’s financial condition, results of operations, cash flows and completion of a Business Combination is not determinable as of the date of these unaudited condensed financial statements.

~~Recent changes~~On inJuly ~~international~~4, ~~trade~~2025, ~~policies~~President Trump signed into law the One Big Beautiful Bill Act (“OBBBA”). ASC 740, ~~tariffs~~“Income ~~and~~Taxes”, ~~macroeconomic~~requires ~~conditions~~the ~~have~~effects ~~created~~of ~~and~~changes ~~are~~in ~~expected~~tax laws to ~~create~~be ~~global~~recognized ~~economic consequences.~~in ~~The~~the ~~specific~~period ~~impact~~in onwhich the legislation is enacted. The Company’s ~~financial~~is ~~condition,~~currently ~~results~~evaluating the impact of ~~operations~~the new law. However, ~~cash~~none ~~flows~~of ~~and~~the ~~completion~~tax ofprovisions aare ~~Business Combination~~expected isto ~~not~~have ~~determinable~~a assignificant ofimpact on the ~~date~~Company’s ofunaudited ~~these~~condensed financial statements.

On July 4, 2025, President Trump signed into law the One Big Beautiful Bill Act (“OBBBA”). ASC 740, “Income Taxes”, requires the effects of changes in tax laws to be recognized in the period in which the legislation is enacted. The Company is currently evaluating the impact of the new law. However, none of the tax provisions are expected to have a significant impact on the Company’s financial statements.

Note 2 — Significant Accounting Policies

Basis of Presentation

The accompanying unaudited condensed financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for financial information and pursuant to the rules and regulations of the SEC. Accordingly, they do not include all of the information and footnotes required by GAAP. In the opinion of management, the unaudited condensed financial statements reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the balances and results for the periods presented. Operating results for the three ~~and nine~~ months ended ~~September~~March 3031, ~~2025~~2026 are not necessarily indicative of the results that may be expected through December 31, ~~2025~~2026.

The accompanying unaudited condensed financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Form 10-K filed by the Company with the SEC on ~~December~~March 231, ~~2025~~2026.

Segment Reporting

The Company complies with ASC Topic 280, “Segment Reporting,” which improves reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses among other disclosure requirements. The Company adopted ASC Topic 280 on January 1, 2025. The amendments will be applied retrospectively to all prior periods presented in the unaudited condensed financial statements (see Note 10).

Emerging Growth Company Status

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart our Business Startups Act of 2012, (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.9

10Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s unaudited condensed financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

Use of Estimates

The preparation of these unaudited condensed financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.

Cash and Cash Equivalents

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had $425 of cash and no cash equivalents as of ~~September~~March 3031, ~~2025~~2026 and December 31, ~~2024~~2025.

Investments Held in Trust Account

As of ~~September~~March 3031, ~~2025~~2026 and December 31, ~~2024~~2025, the Trust Account had $5,~~732~~744,~~823~~230 and $5,~~804~~788,~~083~~250, respectively, held in marketable securities. Such securities are presented on the balance sheets at fair value at the end of the reporting period. Dividends earned on these securities are included in trust dividend income in the accompanying ~~unaudited condensed~~ statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information. ~~During~~For the three ~~and nine~~ months ended ~~September 30,~~March ~~2025~~31, ~~the~~2026 ~~Company withdrew $0~~ and ~~$250~~2025,~~057,~~ ~~respectively, of principal and dividend income from~~ the ~~Trust Account in connection with redemptions. During the three and nine months ended September 30, 2024, the~~ Company withdrew $1694,~~484,256~~580 and $400,~~209,102,~~ respectively, of principal and ~~interest~~dividend income from the Trust Account in connection with redemptions.

Concentration of Credit Risk

Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. At ~~September~~March 3031, ~~2025~~2026 and December 31,~~2024~~ 2025, the Company has not experienced losses on this account.

Class A Ordinary Shares Subject to Possible Redemption

The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Class A ordinary shares subject to mandatory redemption are classified as a liability instrument and are measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, as of ~~September~~March 3031, ~~2025~~ 2026 and December 31, ~~2024~~2025, ~~491,806 and 513,613, respectively,~~ shares of Class A ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ deficit section of the Company’s balance sheets.

11As of March 31, 2026 and December 31, 2025, the ordinary shares subject to possible redemption reflected on the balance sheets are reconciled in the following table:

As of September 30, 2025 and December 31, 2024, the ordinary shares subject to possible redemption reflected on the balance sheets are reconciled in the following table:

	Shares			Amount
Ordinary shares subject to possible redemption, December 31, 2024		513,613			5,804,083
Less:
Redemption		(21,807	)		(250,057	)
Plus:
Remeasurement of carrying value to redemption value		—			234,224
Ordinary shares subject to possible redemption, December 31, 2025		491,806		$	5,788,250
Less:
Redemption		(7,984	)		(94,580	)
Plus:
Remeasurement of carrying value to redemption value		—			50,560
Ordinary shares subject to possible redemption, March 31, 2026		483,822		$	5,744,230

	Shares			Amount
Ordinary shares subject to possible redemption, December 31, 2023		4,196,485		$	45,065,840
Less:
Redemption		(3,682,872	)		(40,209,102	)
Plus:
Remeasurement of carrying value to redemption value		—			947,345
Ordinary shares subject to possible redemption, December 31, 2024		513,613			5,804,083
Plus:
Remeasurement of carrying value to redemption value		—			60,666
Ordinary shares subject to possible redemption, March 31, 2025		513,613			5,864,749
Less:
Redemption		(21,807	)		(250,057	)
Plus:
Remeasurement of carrying value to redemption value		—			59,442
Ordinary shares subject to possible redemption, June 30, 2025		491,806			5,674,134
Plus:
Remeasurement of carrying value to redemption value		—			58,689
Ordinary shares subject to possible redemption, September 30, 2025		491,806		$	5,732,823

Net Loss per Ordinary Shares

The Company has two classes of shares, which are referred to as redeemable Class A ordinary shares and non-redeemable Class B ordinary shares. Earnings and losses are shared pro rata between the two classes of shares. Private and public warrants to purchase 14,213,333 Class A ordinary shares at $11.50 per share were issued on February 11, 2021. No warrants were exercised during the three ~~and nine~~ months ended ~~September~~March 3031, ~~2025~~2026 or ~~2024~~2025. The calculation of diluted loss per ordinary share does not consider the effect of the warrants issued in connection with the (i) IPO, (ii) exercise of over-allotment, and (iii) Private Placement since the exercise of the warrants are contingent upon the occurrence of future events. As a result, diluted net loss per ordinary share is the same as basic net loss per ordinary share for the periods.

	For the Three Months Ended September 30,												For the Nine Months Ended September 30,
	For the Three Months Ended March 31,
	2025						2024						2025						2024
	2026						2025
	Redeemable Class A			Non- redeemable Class B			Redeemable Class A			Non- redeemable Class B			~~Redeemable Class A~~			~~Non- redeemable Class B~~			~~Redeemable Class A~~			~~Non- redeemable Class B~~
Basic and diluted net loss per share
Numerator:
Allocation of net loss	$	(1268,~~454~~219	)	$	(~~174~~961,~~733~~088	)	$	(2449,~~305~~336	)	$	(~~136~~662,~~922~~791	)	$	~~(142,700~~	)	$	~~(1,961,292~~	)	$	~~(59,320~~	)	$	~~(199,928~~	)
Denominator
Weighted-average shares outstanding		~~491~~489,~~806~~766			6,900,000			1513,~~224,799~~613			6,900,000			~~502,031~~			~~6,900,000~~			~~2,047,258~~			~~6,900,000~~
Basic and diluted net loss per share	$	(0.0314	)	$	(0.0314	)	$	(0.0210	)	$	(0.0210	)	$	~~(0.28~~	)	$	~~(0.28~~	)	$	~~(0.03~~	)	$	~~(0.03~~	)

Share Based Compensation

The Company complies with ASC 718 Compensation—Stock Compensation regarding Founder Shares acquired by directors and independent advisors of the Company at prices below fair value. The acquired shares vested upon granting of the shares. The Founder Shares owned by the director (1) may not be sold or transferred, until one year after the consummation of a Business Combination, (2) are not entitled to redemption from the funds held in the Trust Account, or any liquidating distributions. If the Company does not consummate a Business Combination during the Combination Period, the Company will liquidate and the shares will become worthless.

Fair Value of Financial Instruments

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under the Financial Accounting Standards Board (“FASB”) ASC 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the balance sheets.

Derivative Warrant Liabilities

The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants and working capital loan options, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and ASC 815-15. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period.

The Company accounts for its 14,213,333 ordinary share warrants issued in connection with its IPO (9,200,000) and Private Placement (5,013,333) as derivative warrant liabilities in accordance with ASC 815-40. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the instruments to fair value at each reporting period. The liabilities are subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s statements of operations.

~~Working Capital Loans Option~~11

On November 30, 2021, Richard Chera, the Company’s former Chief Executive Officer and director agreed to loan the Company up to $1,500,000 to be used for a portion of the expenses of the Company (“Working Capital Loan”). At December 31, 2022, at the option of Richard Chera, the outstanding principal of $666,000 may be converted into that number of warrants equal to the outstanding principal of the note divided by $1.50 (444,000 warrants). The option (“Working Capital Loan Option”) to convert the Working Capital Loan into warrants qualified as an embedded derivative under ASC 815 and was required to be reported at fair value. On May 31, 2023, Richard Chera agreed to waive the right to convert the amounts due under the Working Capital Loan into warrants. At September 30, 2025 and December 31, 2024, the Working Capital Loan Option no longer existed. In accordance with ASC Topic 470, “Liabilities” the Company has determined the waiver of the right to convert is a debt modification. Given the warrants had no significant value at the time of the debt modification, there is no effect on the Company’s financial statements for the debt modification.

Income Taxes

The Company accounts for income taxes under ASC Topic 740, “Income Taxes,” which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the unaudited condensed financial statements and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.

ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the unaudited condensed financial statements recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company’s management determined that the Cayman Islands is the Company’s major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. As of ~~September~~March 3031, ~~2025~~2026 and December 31, ~~2024~~2025, there were no unrecognized tax benefits and no amounts accrued for interest and penalties. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.

The Company is considered to be an exempted Cayman Islands company with no connection to any other taxable jurisdiction and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. As such, the Company’s tax provision was zero for the period presented.

Recent Accounting Standards

Management does not believe that any recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company’s unaudited condensed financial statements.

Non-Redemption Agreements

In February 2024, the Company and CIIG entered into Non-Redemption Agreements with Non-Redeeming Investors. The Non-Redemption Agreements provide for the assignment of economic interest of an aggregate of 464,414 Class B ordinary shares held by CIIG to the Non-Redeeming Investors in exchange for such Non-Redeeming Investors agreeing to hold and not redeem an aggregate of 1,857,655 Class A ordinary shares at the February 2024 Extraordinary General Meeting. Pursuant to the Non-Redemption Agreements, CIIG has agreed to transfer to such Non-Redeeming Investors an aggregate of 464,414 Class A ordinary shares upon conversion of the Class B ordinary shares in connection with the consummation of an initial Business Combination. The aggregate fair value of the 464,414 Class B ordinary shares attributable to the Non-Redeeming Investors amounted to $375,981 or $0.81 per share.

Beginning on August 8, 2024, and continuing until the August 9, 2024 Extraordinary General Meeting, the Company and CIIG entered into Non-Redemption Agreements with the Non-Redeeming Investors. The Non-Redemption Agreements provide for the assignment of economic interest of an aggregate of 115,287 Class B ordinary shares held by CIIG to the Non-Redeeming Investors in exchange for such Non-Redeeming Investors agreeing to hold and not redeem an aggregate of 461,146 Class A ordinary shares at the August 9, 2024 Extraordinary General Meeting. Pursuant to the Non-Redemption Agreements, CIIG has agreed to transfer to such Non-Redeeming Investors an aggregate of 115,287 Class A ordinary shares upon conversion of the Class B ordinary shares in connection with the consummation of an initial Business Combination. The Company estimated the aggregate fair value of the 115,287 Class B ordinary shares attributable to the Non-Redeeming Investors to be $75,341 or $0.65 per share.

Beginning on May 6, 2025, and continuing until the May 9, 2025 Extraordinary General Meeting, the Company and CIIG entered into Non-Redemption Agreements with the Non-Redeeming Investors. The Non-Redemption Agreements provide for the assignment of economic interest of an aggregate of 115,287 Class B ordinary shares held by CIIG to the Non-Redeeming Investors in exchange for such Non-Redeeming Investors agreeing to hold and not redeem an aggregate of 461,146 Class A ordinary shares at the May 9, 2025 Extraordinary General Meeting. Pursuant to the Non-Redemption Agreements, CIIG has agreed to transfer to such Non-Redeeming Investors an aggregate of 115,287 Class A ordinary shares upon conversion of the Class B ordinary shares in connection with the consummation of an initial Business Combination. The Company estimated the aggregate fair value of the 115,287 Class B ordinary shares attributable to the Non-Redeeming Investors to be $223,138 or $1.94 per share.

Each Non-Redeeming Investor acquired from the Sponsors an indirect economic interest in the Founder Shares. The value of the Non-Redemption Agreements is reported as a component of shareholders’ deficit. The excess of the fair value of the Founder Shares was determined to be non-redemption agreement expense in accordance with SAB Topic 5T.

Loan Extension Agreement

On February 10, 2026, the A&R Note (discussed in Note 5) was amended to replace “February 11, 2026” with December 31, 2026 (the “Third A&R Note”). In connection with the execution of the Third A&R Note, CIIG Management III LLC has agreed to transfer additional Class B Ordinary Shares upon consummation of a Business Combination to an unaffiliated third party in an amount equal to the product of the number of months from February 2026 until the date on which Company consummates a Business Combination and 2,500 and subject to the same transfer restrictions that are imposed on CIIG Management III LLC (the “Loan Extension Agreement”). The Company complies with Staff Accounting Bulletin Topic 5T and recognize a capital contribution, as the potential transfer of these shares is a benefit to the Company

As of March 31, 2026, the Loan Extension Agreement accrued 5,000 Class B ordinary shares. The Company estimated the aggregate fair value of the 5,000 Class B ordinary shares attributable to the Loan Extension Agreement, for the period ended March 31, 2026, to be $10,362. This implies a value of $1.97 per share for the 2,500 Class B ordinary shares that vested on February 10, 2026 and $2.17 per share for the additional 2,500 Class B ordinary shares that vested in March.

The value of the Loan Extension Agreements is reported as a component of shareholders’ deficit. The excess of the fair value of the Founder Shares was determined to be Loan Extension Agreement expense in accordance with SAB Topic 5T.

Note 3 — Initial Public Offering

Pursuant to the IPO, the Company sold 27,600,000 Units, at a price of $10.00 per Unit. Each Unit consists of one Class A ordinary share, par value $0.0001 per share, and one-third of one redeemable warrant (“Public Warrant”). Each whole Public Warrant entitles the holder to purchase one Class A ordinary share at a price of $11.50 per share.

Note 4 — Private Placement Warrants

Simultaneously with the closing of the IPO, Crown PropTech Sponsor and certain funds and accounts managed by subsidiaries of BlackRock, Inc. (collectively, the “Anchor Investor”) purchased an aggregate of 5,013,333 Private Placement Warrants at a price of $1.50 per warrant ($7,520,000 in the aggregate), each Private Placement Warrant is exercisable to purchase one Class A ordinary share at a price of $11.50 per share. A portion of the purchase price of the Private Placement Warrants was added to the proceeds from the IPO to be held in the Trust Account.

Note 5 — Related Party Transactions

Founder Shares

On October 13, 2020, the Company issued 5,750,000 Class B ordinary shares to Crown PropTech Sponsor for an aggregate purchase price of $25,000 (the “Founder Shares”). On February 9, 2021, the Company effected a dividend of 0.2 of a Class B ordinary share for each Class B ordinary share, resulting in 6,900,000 Class B ordinary shares being issued and outstanding.

On February 11, 2021, Crown PropTech Sponsor transferred 690,000 Founder Shares to the Anchor Investors for $2,500. In February 2021, Crown PropTech Sponsor transferred an aggregate of 250,000 Founder Shares to four of the Company’s independent directors and two independent advisors. Immediately after transferring shares to the Anchor Investors, directors and advisors, Crown PropTech Sponsor owned 5,960,000 Founder Shares.

On January 17, 2023, CIIG entered into the Assignment Agreement, by and among Crown PropTech Sponsor, CIIG and Richard Chera, whereby the Crown PropTech Sponsor sold, transferred and assigned 5,662,000 Class B ordinary shares of the Company and 250,667 private placement warrants to purchase Class A ordinary shares of the Company to CIIG. Total consideration paid by CIIG for the class B ordinary shares and private placement warrants was $21,717.

Crown PropTech Sponsor, CIIG and the Anchor Investor have agreed, subject to limited exceptions, not to transfer, assign or sell any Founder Shares until the earlier to occur of (i) one year after the completion of a Business Combination or (ii) the date following the completion of a Business Combination on which the Company completes a liquidation, merger, share exchange or other similar transaction that results in all of the shareholders having the right to exchange their ordinary shares for cash, securities or other property. Notwithstanding the foregoing, if the closing price of the Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share splits, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after a Business Combination, the Founder Shares will be released from the lockup.

1513

Working Capital Loans

In order to finance transaction costs in connection with a Business Combination, the initial shareholders or an affiliate of the initial shareholders or certain of the Company’s directors and officers may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination is not consummated, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1,500,000 of such Working Capital Loans may be convertible into warrants of the post-Business Combination entity at a price of $1.50 per warrant. The warrants would be identical to the Private Placement Warrants.

On November 30, 2021, the Company entered into a convertible note with Richard Chera, its former Chief Executive Officer and director, pursuant to which Mr. Chera agreed to loan the Company up to an aggregate principal amount of $1,500,000 (the “Convertible Note”). The Convertible Note was non-interest bearing and due on the earlier of: (i) 12 months from the date thereof or (ii) the date on which the Company consummates a Business Combination. If the Company does not consummate a Business Combination, the Company may use a portion of any funds held outside the Trust Account to repay the Convertible Note; however, no proceeds from the Trust Account may be used for such repayment if the Company does not consummate the Business Combination. Up to $1,500,000 of the Convertible Note ~~may~~ becould have been converted into warrants identical to the Private Placement Warrants at a price of $1.50 per warrant at the option of Mr. Chera (the “Conversion Right”). ~~The~~ ~~warrants would be identical to the Private Placement Warrants.~~

On May 31, 2023, the Convertible Note was amended and restated (the “A&R Note”) in the aggregate principal amount of up to $1,000,000 to be due on the earlier of: (i) February 11, 2024; (ii) the date on which the Company consummates a Business Combination; or (iii) the effective date of a liquidation of the Company. Additionally, due to a waiver by Mr. Chera, the A&R Note no longer provides for the Conversion Right.

On March 28, 2025, the A&R Note in the aggregate principal amount of up to $1,000,000 was amended to be due on the earlier of: (i) February 11, 2026; (ii) the date on which the Company consummates a Business Combination; or (iii) the effective date of a liquidation of the Company.

As ofOn ~~September~~February 3010, ~~2025~~2026, ~~CIIG~~the ~~has~~A&R ~~advanced~~Note ~~funds~~was amended to ~~and~~replace ~~paid~~“February ~~expenses~~11, on2026” ~~behalf~~with ofDecember 31, 2026 (the ~~Company~~“Third inA&R Note”). In connection with the ~~amount~~execution of ~~$539,934.~~the OfThird ~~these~~A&R ~~funds~~Note, ~~$419,978~~ isCIIG ~~reported~~Management asIII ~~due~~LLC has agreed to ~~related~~transfer ~~parties~~additional Class B Ordinary Shares upon consummation of a Business Combination to an unaffiliated third party in an amount equal to the product of the number of months from February 2026 until the date on which Company consummates a Business Combination and 2,500 and subject to the ~~balance~~same ~~sheet.~~transfer ~~These~~restrictions ~~borrowings~~that are ~~non-interest~~imposed ~~bearing~~on CIIG Management III LLC. ~~The~~Upon ~~remaining~~consummation ~~$119~~of a Business Combination,~~956~~ the Company will comply with Staff Accounting Bulletin Topic 5T and recognize As the potential transfer of these shares is ~~reported~~contingent onupon the ~~statements~~close of ~~changes~~a inBusiness ~~shareholders’~~Combination, ~~deficit~~the asCompany has not recognized an expense or a liability (depending on the underlying transaction) and an increase in additional-paid-in capital ~~contribution~~for ~~from~~the ~~Sponsor~~fair value of the shares transferred.

~~Borrowing~~ ~~under~~As ~~the~~of ~~A&R~~March ~~Note~~31, ~~and~~2026, ~~the~~CIIG ~~advances from~~has ~~CIIG~~advanced ~~are~~funds ~~reported~~to and paid expenses on behalf of the ~~balance~~Company ~~sheets~~in the amount of $1,779,215. Of these funds, $444,667 is reported as due to related parties. Aton ~~September~~the ~~30,~~balance ~~2025~~sheets. ~~and~~These ~~December~~borrowings ~~31,~~are ~~2024,~~non-interest ~~the~~bearing. ~~Company~~The ~~reported $1,567,897~~remaining ~~and~~ $1,~~189~~334,~~077,~~549 ~~respectively,~~is reported on the ~~balance~~statements ~~sheets~~of changes in shareholders’ deficit as a capital contribution from Sponsor.

On ~~June~~Borrowing 2,under ~~2025,~~the ~~Lancaster~~A&R ~~agreed~~Note toand ~~issue~~the ~~and sell~~advances afrom ~~convertible~~CIIG ~~promissory~~are ~~note~~reported toon anthe ~~affiliate~~balance ofsheets ~~the~~as ~~Company’s~~due ~~Chairman~~to related parties (~~the~~excluding ~~“Investor”)~~$1,334,549 inof ~~connection~~advances ~~with~~from ~~the Proposed~~CIIG ~~Business~~that ~~Combination~~are ~~with~~reported aon ~~principal~~the ~~amount~~statements of ~~$500,000 (the~~changes ~~“BCA~~in ~~Note”),~~shareholders’ deficit as ~~described~~a incapital ~~the~~contribution). ~~Note~~At ~~Purchase Agreement~~March in31, 2026 and December 31, 2025, the Company’s ~~Form~~reported ~~8-K~~$1,592,586 ~~filed~~on ~~with~~ the ~~SEC~~balance onsheets ~~June~~as 3,due ~~2025~~to related parties.

~~The Company’s~~ ~~CEO~~On ~~and~~June an2, ~~affiliated~~2025, ~~entity~~MKAR ofagreed ~~the~~to ~~CEO,~~issue ~~entered~~and ~~into~~sell a ~~letter~~convertible ~~agreement~~promissory ~~(the~~note ~~“Letter~~to ~~Agreement”)~~an ~~with~~affiliate ~~the Investor.~~of ~~The Letter Agreement includes a put option buyout by~~ the Company’s ~~CEO~~Chairman ~~and/or an affiliated entity of~~ (the ~~CEO~~“Investor”) in ~~the event~~connection ifwith ~~for~~the ~~any~~Proposed ~~reason~~Business ~~whatsoever~~Combination ~~Investor~~with isa ~~entitled~~principal toamount ~~the repayment~~ of $500,000 (the “BCA Note ~~(including~~”), ~~without~~as ~~limitation~~described ~~unpaid~~in ~~and~~the ~~accrued interest~~Note ~~and~~Purchase ~~other~~Agreement ~~charges~~in ~~owing~~the ~~pursuant~~Company’s toForm ~~the~~8-K ~~terms~~filed ofwith the ~~BCA~~SEC ~~Note),~~on ~~and~~June ~~such~~3, ~~payment was not timely made by Lancaster~~2025.

In connection with the previously disclosed $750,000 Note Purchase Agreement (the “NPA”) entered into with MKAR on June 3, 2025, CIIG Management III LLC, in its capacity as the F-4 Note Investor, funded the remaining $250,000 in connection with the confidential submission of the Form F-4 in exchange for MKAR’s issuance of a convertible promissory note on February 13, 2026.

The Company’s CEO and an affiliated entity of the CEO, entered into a letter agreement (the “Letter Agreement”) with the Investor. The Letter Agreement includes a put option buyout by the Company’s CEO and/or an affiliated entity of the CEO in the event if for any reason whatsoever Investor is entitled to the repayment of the BCA Note (including, without limitation unpaid and accrued interest and other charges owing pursuant to the terms of the BCA Note), and such payment was not timely made by MKAR.

Note 6 — Commitments & Contingencies

Registration Rights

The holders of the Founder Shares, Private Placement Warrants and any warrants that may be issued upon conversion of Working Capital Loans (and any ordinary shares issuable upon the exercise of the Private Placement Warrants or warrants issued upon conversion of the Working Capital Loans and upon conversion of the Founder Shares) will be entitled to registration rights pursuant to a registration rights agreement to be signed prior to or on the effective date of the IPO requiring the Company to register such securities for resale. The holders of these securities will be entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of a Business Combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

Financial Advisor Service Agreement

On June 1, 2025, the Company engaged Jett Capital as financial advisor to advise the Company on their proposed Business Combination with ~~Lancaster~~ ~~Exploration~~MKAR Limited, Mkango Polska S.P.Z.O.O., MKA BVI, and Mkango ServiceCo UK Limited.

The Company has agreed to pay Jett Capital as follows:

Work Fee

A work fee of $100,000 upon the execution of the agreement. As of the filing of this Form 10-Q, this work fee has not been paid.

In the event that the proceeds (net of offering fees paid to advisors in the offering(s)) raised in connection with the Business Combination are $15.0 million, or less, Jett Capital shall receive a cash transaction fee equal to $2.5 million with $500,000 of the cash transaction fee paid at close of the Business Combination, and $2.0 million of the cash transaction fee deferred and payable upon close of the first offering completed by Mkango following the Business Combination.

ii.

In the event that the proceeds (net of offering fees paid to advisors in the offering(s)) raised in connection with the Business Combination are greater than $15.0 million, but less than $25.0 million, Jett Capital shall receive a cash transaction fee equal to $2.5 million with the cash transaction fee paid at close of the Business Combination equal to 50% of every dollar in proceeds (net of offering fees) above $15.0 million paid in cash up to a total of $2.5 million and any remaining balance owed on the $2.5 million cash transaction fee deferred and payable upon close of the first offering completed by Mkango following the Business Combination.

iii.

In the event that the proceeds (net of offering fees paid to advisors in the offering(s)) raised in connection with the Business Combination are equal to or greater than $25.0 million, but less than $35.0 million, Jett Capital shall receive a cash transaction fee equal to $4.5 million with $2.5 million of the cash transaction fee paid at close of the Business Combination. and $2.0 million of the cash transaction fee deferred and payable upon close of the first offering completed by Mkango following the Business Combination.

iv.

In the event that the proceeds (net of offering fees paid to advisors in the offering(s)) raised in connection with the Business Combination are equal to greater than $35.0 million, Jett Capital shall receive a cash transaction fee equal to $4.5 million at close of the Business Combination.

Offering Fee; Business Combination PIPE

For any offering, or combination of offerings that provide incremental gross proceeds beyond the Trust Account of the Company to Mkango at close of the Business Combination (the “Business Combination PIPE” or the “PIPE”), Jett Capital shall be a Joint-Placement Agent in this PIPE with Cohen & Company Capital Markets (“CCM”), each collecting fifty percent (50.0%) of a cash fee equal to four and a half percent (4.5%) of the gross proceeds raised in the PIPE.

Offering Fee; Equity Offering

Upon the Company closing an equity or equity-linked offering following the close of the Business Combination, Jett Capital shall be a Joint Placement Agent in the equity or equity-linked Offering and receive 50% of a cash fee equal to six percent (6.0%) of the total offering size payable at offering close from immediately available funds.

Offering Fee; Debt Offering

Upon the Company closing a debt offering following the close of the proposed Business Combination, Jett Capital shall be a Joint Placement Agent in the debt offering and receive 50% of a cash fee equal to three percent (3.0%) of the total Offering size payable at offering close from immediately available funds.

Note 7 — Shareholders’ Deficit

Preference Shares —The Company is authorized to issue a total of 1,000,000 preference shares at par value of $0.0001 each. As of ~~September 30~~March 31, ~~2025~~2026 and December 31, ~~2024~~2025, there were no preference shares issued or outstanding.

Class A Ordinary Shares —The Company is authorized to issue a total of 200,000,000 Class A ordinary shares at par value of $0.0001 each. At ~~September~~March 3031, ~~2025~~2026 and December 31, ~~2024~~2025, there were no shares issued and outstanding (excluding ~~491~~483,~~806~~822 and ~~513~~491,~~613~~ 806 shares subject to possible redemption, respectively).

Class B Ordinary Shares —The Company is authorized to issue a total of 20,000,000 Class B ordinary shares at par value of $0.0001 each. At ~~September~~March 3031, ~~2025~~2026 and December 31, ~~2024~~2025, there were 6,900,000 Class B ordinary shares issued or outstanding.

Holders of Class A ordinary shares and Class B ordinary shares will vote together as a single class on all other matters submitted to a vote of shareholders, except as required by law; provided that only holders of Class B ordinary shares have the right to vote on the appointment of directors prior to the Company’s initial Business Combination.

The Class B ordinary shares will automatically convert into Class A ordinary shares concurrently with or immediately following the completion of a Business Combination on a one-for-one basis, subject to adjustment. In the case that additional Class A ordinary shares or equity-linked securities are issued or deemed issued in connection with a Business Combination, the number of Class A ordinary shares issuable upon conversion of all Founder Shares will equal, in the aggregate, 20% of the total number of Class A ordinary shares outstanding after such conversion (after giving effect to any redemptions of Class A ordinary shares by public shareholders), including the total number of Class A ordinary shares issued, or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of a Business Combination, excluding any Class A ordinary shares or equity-linked securities exercisable for or convertible into Class A ordinary shares issued, or to be issued, to any seller in a Business Combination and any Private Placement Warrants issued to the sponsor, officers or directors upon conversion of Working Capital Loans; provided that such conversion of Founder Shares will never occur on a less than one-for-one basis.

Note 8 — Warrants

Public Warrants may only be exercised for a whole number of shares. No fractional warrants will be issued upon separation of the Units and only whole warrants will trade. The Public Warrants become exercisable on the later of (a) 30 days after the completion of a Business Combination and (b) 12 months from the closing of the IPO. The Public Warrants will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation.

The Company will not be obligated to deliver any Class A ordinary shares pursuant to the exercise of a Public Warrant and will have no obligation to settle such Public Warrant exercise unless a registration statement under the Securities Act with respect to the Class A ordinary shares underlying the Public Warrants is then effective and a prospectus relating thereto is current, subject to the Company satisfying its obligations with respect to registration. No Public Warrant will be exercisable and the Company will not be obligated to issue any shares to holders seeking to exercise their warrants, unless the issuance of the shares upon such exercise is registered or qualified under the securities laws of the state of the exercising holder, or an exemption is available.

The Company has agreed that as soon as practicable, but in no event later than 15 business days, after the closing of the Company’s Business Combination, the Company will use its commercially reasonable efforts to file with the SEC a registration statement for the registration, under the Securities Act, of the Class A ordinary shares issuable upon exercise of the warrants. The Company will use its commercially reasonable efforts to cause the same to become effective and to maintain the effectiveness of such registration statement, and a current prospectus relating thereto, until the expiration or redemption of the warrants in accordance with the provisions of the warrant agreement. If a registration statement covering the Class A ordinary shares issuable upon exercise of the warrants is not effective by the 60th business day after the closing of a Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption. Notwithstanding the above, if the Class A ordinary shares are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of public warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, the Company will not be required to file or maintain in effect a registration statement, and in the event the Company does not so elect, it will use its commercially reasonable efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available.

1816

Once the warrants become exercisable, the Company may redeem the Public Warrants for redemption:

●

in whole and not in part;

●

at a price of $0.01 per warrant;

●

upon not less than 30 days’ prior written notice of redemption;

●

to each warrant holder; and

●

if, and only if, the reported closing price of the ordinary shares equals or exceeds $18.00 per share (as adjusted for share splits, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period ending three business days before we send to the notice of redemption to the warrant holders.

If and when the warrants become redeemable by the Company, the Company may exercise its redemption right even if it is unable to register or qualify the underlying securities for sale under all applicable state securities laws. If the Company calls the Public Warrants for redemption, as described above, its management will have the option to require any holder that wishes to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. The exercise price and number of ordinary shares issuable upon exercise of the Public Warrants may be adjusted in certain circumstances including in the event of a share dividend, extraordinary dividend or recapitalization, reorganization, merger or consolidation. However, except as described below, the Public Warrants will not be adjusted for issuances of ordinary shares at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the Public Warrants. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of Public Warrants will not receive any of such funds with respect to their Public Warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with respect to such Public Warrants. Accordingly, the Public Warrants may expire worthless.

In addition, if (x) the Company issues additional Class A ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of a Business Combination at an issue price or effective issue price of less than $9.20 per Class A ordinary share (with such issue price or effective issue price to be determined in good faith by the Board and, in the case of any such issuance to the sponsor or its affiliates, without taking into account any Founder Shares held by the sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of a Business Combination, and (z) the volume weighted average trading price of the Class A ordinary shares during the 20 trading day period starting on the trading day prior to the day on which the Company consummates a Business Combination (such price, the “Market Value”) is below $9.20 per share, then the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $10.00 and $18.00 per share redemption trigger prices will be adjusted (to the nearest cent) to be equal to 100% and 180% of the higher of the Market Value and the Newly Issued Price, respectively.

The Private Placement Warrants are identical to the Public Warrants underlying the Units being sold in the IPO, except that (x) the Private Placement Warrants and the Class A ordinary shares issuable upon the exercise of the Private Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions, (y) the Private Placement Warrants will be exercisable on a cashless basis and be non-redeemable so long as they are held by the initial purchasers or their permitted transferees and (z) the Private Placement Warrants and the Class A ordinary shares issuable upon the exercise of the Private Placement Warrants will be entitled to registration rights. If the Private Placement Warrants are held by someone other than the initial purchasers or their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.

1917

Note 9 — Fair Value Measurements

Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:

●

Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;

●

Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and

●

Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

Recurring Fair Value Measurements

The Company’s permitted investments consist of U.S. Money Market funds. Fair values of these investments are determined by Level 1 inputs utilizing quoted prices (unadjusted) in active markets for identical assets.

The Company’s warrant liability for the Public Warrants is based on unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access. At ~~September~~March 3031, ~~2025~~2026 and December 31, ~~2024~~2025, there was insufficient trading activity for the Public Warrants to be classified as Level 1 and was classified as Level 2.

The Company’s management has determined the Private Warrants are economically equivalent to the Public Warrants. As such, the valuation of the Private Warrants is based on the valuation of the Public Warrants. The fair value of the Private Warrant liability is classified within Level 2 of the fair value hierarchy due to the Company using quoted prices for similar instruments in active markets.

The following table presents fair value information of the Company’s financial assets and liabilities that were accounted for at fair value on a recurring basis and indicates the fair value hierarchy of the valuation techniques the Company utilized to determine such fair value.

September 30, 2025

Level 1

Level 2

Level 3

March 31, 2026

Level 1

Level 2

Level 3

Description

Assets:

Investments held in Trust Account

5,~~732~~744,~~823~~230

—

Liabilities:

Public Warrants

—

Private Warrants

—

Fair Value of warrants

—

December 31, 2025	Level 1		Level 2		Level 3
Description
Assets:
Investments held in Trust Account	$	5,788,250	$	—	$	—

Liabilities:
Public Warrants	$	—	$	—	$	—
Private Warrants		—		—		—
Fair Value of warrants	$	—	$	—	$	—

December 31, 2024	Level 1		Level 2		Level 3
Description
Assets:
Investments held in Trust Account	$	5,804,083	$	—	$	—
Liabilities:
Public Warrants	$	—	$	9	$	—
Private Warrants		—		5		—
Fair Value of warrants	$	—	$	14	$	—

Note 10 — Segment Information

ASC Topic 280, “Segment Reporting,” establishes standards for companies to report in their unaudited condensed financial statement information about operating segments, products, services, geographic areas, and major customers. Operating segments are defined as components of an enterprise that engage in business activities from which it may recognize revenues and incur expenses, and for which separate financial information is available that is regularly evaluated by the Company’s chief operating decision maker (“CODM”), or group, in deciding how to allocate resources and assess performance.

The Company’s CODM has been identified as the Chief Executive Officer who reviews the assets, operating results, and financial metrics for the Company as a whole to make decisions about allocating resources and assessing financial performance. Accordingly, management has determined that there is only one reportable segment.

The CODM assesses performance for the single segment and decides how to allocate resources based on net income or loss that also is reported on the ~~condensed~~ statements of operations as net income or loss. The measure of segment assets is reported on the ~~condensed~~ balance sheets as total assets. When evaluating the Company’s performance and making key decisions regarding resource allocation, the CODM reviews several key metrics included in net income or loss and total assets, which include the following:

	September 30,		December 31,
	March 31,		December 31,
	2025		2024
	2026		2025
Cash	$	425	$	425
Investments held in Trust Account	$	5,~~732~~744,~~823~~230	$	5,~~804~~788,~~083~~250
Total assets	$	5,~~815~~782,~~528~~834	$	5,~~806~~789,~~102~~667

	For the Three Months Ended September 30,						For the Nine Months Ended September 30,
	For the Three Months Ended March 31,
	2025			2024			2025			2024
	2026			2025
Operating costs	$	(~~281~~1,~~409~~069,505	)	$	(~~260~~772,~~603~~793	)	$	~~(2,059,665~~	)	$	~~(688,859~~	)
Trust dividend income	$	5850,~~689~~560		$	~~174~~60,~~717~~666		$	~~178,797~~		$	~~880,933~~
Net loss	$	(~~187~~1,~~187~~029,307	)	$	(~~161~~712,~~227~~127	)	$	~~(2,103,992~~	)	$	~~(259,248~~	)

The CODM reviews Trust dividend income to measure and monitor shareholder value and determine the most effective strategy of investment with the Trust Account funds while maintaining compliance with the Trust Agreement.

Operating costs are reviewed and monitored by the CODM to manage and forecast cash to ensure enough capital is available to complete a Business Combination or similar transaction within the Combination Period. The CODM also reviews operating costs to manage, maintain and enforce all contractual agreements to ensure costs are aligned with all agreements and budget. Operating costs, are the significant segment expenses provided to the CODM on a regular basis.

Note 11 — Subsequent Events

The Company evaluated subsequent events and transactions that occurred after the balance sheet date through the date that the unaudited condensed financial statements were issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the unaudited condensed financial statements.

2119

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

References to the “Company,” “Crown,” “our,” “us” or “we” refer to Crown PropTech Acquisitions. The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with the unaudited condensed financial statements and the notes thereto contained elsewhere in this report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.

Cautionary Note Regarding Forward-Looking Statements

This Quarterly Report on Form 10-Q includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). We have based these forward-looking statements on our current expectations and projections about future events. These forward-looking statements are subject to known and unknown risks, uncertainties and assumptions about us that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “would” or the negative of such terms or other similar expressions. Such statements include, but are not limited to, possible business combinations and the financing thereof, and related matters, as well as all other statements other than statements of historical fact included in this Form 10-Q. Factors that might cause or contribute to such a discrepancy include, but are not limited to, those described in our other Securities and Exchange Commission (“SEC”) filings.

Overview

We are a blank check company incorporated as a Cayman Islands exempted company on September 24, 2020 for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (a “business combination”). Our sponsors are Crown PropTech Sponsor, LLC (“Crown PropTech Sponsor”), a Delaware limited liability company and CIIG Management III LLC (“CIIG”), a Delaware limited liability company, (each, a “sponsor” and together, the “sponsors”).

The registration statement for our initial public offering (the “IPO”) became effective on February 8, 2021. On February 11, 2021, we consummated the IPO of 27,600,000 units, which included the exercise of the underwriters’ option to purchase an additional 3,600,000 units at the IPO price to cover over-allotments (the “Units” with respect to the Class A ordinary shares included in the Units being offered, the “Public Shares” with respect to the one-third of one redeemable warrant included in such Units the “Public Warrant”), at $10.00 per Unit, generating gross proceeds of $276.0 million, and incurring offering costs of approximately $15.8 million, inclusive of approximately $9.66 million in deferred underwriting commissions.

Simultaneously with the closing of the IPO, we consummated the private placement (“Private Placement”) of 5,013,333 warrants (each, a “Private Placement Warrant” and collectively, the “Private Placement Warrants”), at a price of $1.50 per Private Placement Warrant with Crown PropTech Sponsor, generating gross proceeds of approximately $7.5 million.

Upon the closing of the IPO and the Private Placement, approximately $276.0 million ($10.00 per Unit) of the net proceeds of the IPO and certain of the proceeds of the Private Placement were placed in a Trust Account (“Trust Account”), located in the United States with Continental Stock Transfer & Trust Company acting as trustee, and invested only in United States “government securities” within the meaning of Section 2(a)(16) of the Investment Company Act having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations, as determined by us, until the earlier of: (i) the completion of a business combination and (ii) the distribution of the Trust Account as described below.

2220

Change in Management

On January 17, 2023, CIIG entered into a Securities Assignment Agreement (the “Assignment Agreement”), by and among Crown PropTech Sponsor, LLC (“Crown PropTech Sponsor”), CIIG and Richard Chera, whereby Crown PropTech Sponsor sold, transferred and assigned 5,662,000 Class B ordinary shares of the Company and 250,667 private placement warrants to purchase Class A ordinary shares of the Company to CIIG. In connection with entry into the Assignment Agreement, CIIG (i) entered into a letter agreement with the Company (the “January 2023 Letter Agreement”) and (ii) entered into a joinder agreement to the Registration Rights Agreement entered into by Crown PropTech Sponsor in connection with the Company’s IPO. As a result of the above transaction CIIG became a co-sponsor to Crown (and together with Crown PropTech Sponsor, the “Sponsors”).

On February 15, 2024, Gavin Cuneo notified the Company of his decision to resign as the co-chief executive officer of the Company, effective immediately. Mr. Cuneo also served as the Company's principal financial and accounting officer and resigned from such positions as well. Mr. Cuneo's decision to resign was not the result of any dispute or disagreement with the Company or any matter relating to the Company's operations, policies or practices.

Michael Minnick, the Company's Chief Executive Officer, assumed the role of principal financial and accounting officer of the Company effective upon Mr. Cuneo's resignation. Mr. Minnick has served as the Company's Co-Chief Executive Officer since January 2023.

Extraordinary General Meetings

February 9, 2024

In connection with the vote to approve the February 2024 Extension Proposal, shareholders holding an aggregate of 2,195,847 shares of the Company’s Class A ordinary shares exercised their right to redeem their shares for a pro rata portion of the funds in the Trust Account (as defined below). As a result, $23,724,846 (approximately $10.80 per share) was withdrawn from the Trust Account to redeem such shares. Following the redemptions, there were 2,000,638 Class A ordinary shares issued and outstanding.

Associated with the February 9, 2024 Extraordinary General Meeting, the Company and CIIG entered into non-redemption agreements (the “February 2024 Non-Redemption Agreements”) with certain investors pursuant to which, if such investors do not redeem (or validly rescind any redemption requests on) their Class A ordinary shares of the Company (the “February 2024 Non-Redeemed Shares”) in connection with the February 9, 2024 Extraordinary General Meeting, CIIG will agree to transfer to such investors Class B ordinary shares held by CIIG immediately following the consummation of an initial Business Combination if they continue to hold such February 2024 Non-Redeemed Shares through the February 9, 2024 Extraordinary General Meeting.

The February 2024 Non-Redemption Agreements provide for the assignment of up to 464,414 Class B ordinary shares, par value $0.0001 per share, held by CIIG to the investors in exchange for such Investors agreeing to hold and not redeem certain public shares at the February 9, 2024 Extraordinary General Meeting.

August 9, 2024

In connection with the vote to approve the August 2024 Extension Proposal, shareholders holding an aggregate of 1,487,025 shares of the Company’s Class A ordinary shares exercised their right to redeem their shares for a pro rata portion of the funds in the Trust Account (as defined below). As a result, $16,484,256 (approximately $11.09 per share) was withdrawn from the Trust Account to redeem such shares. Following the redemptions, there were 513,613 Class A ordinary shares issued and outstanding.

The August 2024 Non-Redemption Agreements provide for the assignment of up to 115,287 Class B ordinary shares, par value $0.0001 per share, held by CIIG to the investors in exchange for such Investors agreeing to hold and not redeem certain public shares at the August 9, 2024 Extraordinary General Meeting.

May 9, 2025

In connection with the vote to approve the May 2025 Extension Proposal, shareholders holding an aggregate of 21,807 shares of the Company’s Class A ordinary shares exercised their right to redeem their shares for a pro rata portion of the funds in the Trust Account (as defined below). As a result approximately, $0.25 million (approximately $11.47 per share) was withdrawn from the Trust Account to redeem such shares. Following the redemptions, there were 491,806 Class A ordinary shares issued and outstanding.

24March 9, 2026

~~Notice~~On March 9, 2026, the Company’s shareholders approved an amendment to amend and restate the Company’s Fifth Amended and Restated Memorandum and Articles of ~~Delisting~~Association to extend the date by which the Company must consummate an initial Business Combination from March 11, 2026 to March 11, 2027 (the “March 2026 Extension Proposal”).

~~On February~~In ~~12,~~connection ~~2024,~~with the ~~NYSE~~vote ~~determined~~to ~~that~~approve the ~~Company~~March 2026 ~~was~~Extension ~~not~~Proposal, inshareholders ~~compliance~~holding ~~with~~an ~~Section~~aggregate ~~802.01B~~of ~~and~~7,984 ~~102.06e~~shares of the ~~NYSE~~Company’s ~~Listed~~Class A ~~Company Manual~~ordinary ~~(the~~shares ~~“LCM”)~~exercised their ~~because~~right ~~the~~to ~~Company~~redeem ~~failed~~their toshares ~~consummate~~for a ~~Business~~pro ~~Combination~~rata ~~within~~portion of the ~~shorter~~funds ofin ~~(i)~~ the ~~time~~Trust ~~period specified~~Account by(as ~~its~~defined ~~constitutive~~below). ~~documents~~As ora byresult, ~~contract~~approximately $0.09 ormillion (~~ii)~~approximately ~~three years~~$11.84 Asper ~~such,~~share) ~~the~~was ~~NYSE~~withdrawn ~~had~~from ~~determined~~the toTrust ~~commence~~Account ~~proceedings~~ (described below) to ~~delist~~redeem ~~from~~such shares. Following the ~~NYSE~~redemptions, ~~the~~there ~~Company’s~~were ~~Class~~483,822 Class A ordinary shares issued and ~~Units~~outstanding.

~~Trading of~~In March 2026 the Company’s ~~securities~~and ~~was~~CIIG ~~suspended~~entered oninto non-redemption ~~February~~agreements ~~12,~~(the ~~2024.~~“March ~~The~~2026 ~~NYSE~~Non-Redemption ~~applied~~Agreements”) towith ~~the~~certain ~~SEC~~investors pursuant to ~~delist~~which, if such investors do not redeem (or validly rescind any redemption requests on) their Class A ordinary shares of the Company’s ~~securities~~(the “March 2026 Non-Redeemed ~~upon~~Shares”) ~~completion~~in ofconnection ~~all~~with ~~applicable~~the ~~procedures~~March 9, 2026 Extraordinary General Meeting, CIIG will assign one Class B ordinary share, par value $0.0001 ~~The~~per ~~Company~~share ~~did~~for ~~not~~each ~~appeal~~40 ~~the~~public ~~staff’s~~shares ~~determination~~not ~~and~~redeemed, ~~accordingly~~accruing monthly beginning April 11, 2026 until the ~~Company’s~~completion of the initial ~~securities~~Business ~~were~~Combination, ~~delisted~~held ~~from~~by CIIG to the ~~NYSE~~investors in exchange for such investors agreeing to hold and not redeem certain public shares at the March 9, 2026 Extraordinary General Meeting.

~~If we~~The ~~have not completed a business combination by~~ March ~~11,~~ 2026 ~~(the~~Non-Redemption ~~“Combination~~Agreements ~~Period”), we will (i) cease all~~provided ~~operations except~~ for the ~~purpose~~assignment of ~~winding~~11,529 ~~up;~~Class ~~(ii) as~~B ~~promptly~~ordinary ~~as reasonably possible but not more than ten business days thereafter~~shares, ~~redeem~~ ~~the~~par ~~Public~~value ~~Shares,~~$0.0001 ~~at a~~ per~~-share~~ ~~price~~share, ~~payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds~~ held inby ~~the~~CIIG ~~Trust Account and not previously released~~ to ~~us to pay our income taxes, if any (less up to $100,000 of interest to pay dissolution expenses) divided by~~ the ~~number of the then-outstanding Public Shares~~investors, ~~which~~accruing ~~redemption will~~monthly ~~completely extinguish Public Shareholders’ rights as shareholders (including the right to receive further liquidation distributions,~~beginning ifApril ~~any); and (iii) as promptly as reasonably possible following such redemption~~11, ~~subject~~2026 tountil the ~~approval~~completion of the ~~remaining~~initial ~~shareholders and~~Business ~~the board of directors~~Combination, ~~liquidate and dissolve, subject~~ in ~~the~~exchange ~~case~~for ofsuch ~~clauses~~Investors ~~(ii) and~~agreeing ~~(iii),~~ to ~~our~~hold ~~obligations under Cayman Islands law to provide for claims of creditors~~ and ~~the~~not ~~requirements of other applicable law. There will be no redemption rights or liquidating~~redeem ~~distributions~~certain ~~with~~public ~~respect~~shares toat ~~our outstanding warrants, which will expire worthless if we fail to consummate a business combination within~~ the ~~Combination~~March ~~Period~~9, ~~including~~2026 ~~any~~Extraordinary ~~extension~~General ~~thereto that may be approved by our shareholders~~Meeting.

Proposed Business Combination

On July 2, 2025, (i) the Company (“SPAC”), (ii) Mkango (Cayman) Limited, an exempted company limited by shares incorporated under the laws of the Cayman Islands and a direct wholly owned Subsidiary of ~~Lancaster~~MKAR (as defined below) (“Merger Sub”), (iii) Mkango Rare Earths Limited (f/k/a Lancaster Exploration Limited), a company organized under the laws of the British Virgin Islands (“~~Lancaster~~MKAR”, and from and after the Closing, “PubCo”), and a direct, wholly owned subsidiary of Mkango Resources Ltd., a company organized under the laws of British Columbia, Canada (the “Selling Shareholder”), (iv) Mkango Polska s.p. Z.o.o., a company organized under the laws of Poland and a direct, wholly owned subsidiary of Selling Shareholder (“MKA Poland”), (v) Mkango ServiceCo UK Limited, a company organized under the laws of England and a direct, wholly owned subsidiary of Selling Shareholder (“Mkango ServiceCo”), and (vi) MKA Exploration Ltd., a company organized under the laws of the British Virgin Islands and a direct, wholly owned subsidiary of Selling Shareholder (“MKA BVI”, and together with ~~Lancaster~~MKAR, MKA Poland and Mkango ServiceCo, the “Companies” and, each, a “Company”) entered into a business combination agreement (the “Business Combination Agreement”).

Amendment No. 1 to Business Combination Agreement

On February 13, 2026, SPAC and MKAR entered into Amendment No. 1 to the Business Combination Agreement (“Amendment No. 1”). Amendment No. 1, among other things, amends the pre-closing internal corporate reorganization to establish the ownership structure so that MKAR will own the assets and operations associated with the rare earth project at Songwe Hill in Malawi and the proposed separation plant to be constructed in Pulawy, Poland and extends the Outside Date from March 11, 2026 to September 30, 2026, with an automatic extension to December 31, 2026 if the U.S. Securities and Exchange Commission (the “SEC”) has not declared the Proxy/Registration Statement effective by August 14, 2026.

Financial Advisor Service Agreement

On June 1, 2025, the Company engaged Jett Capital Advisors, LLC (“Jett Capital”) as financial advisor to advise the Company on their proposed Business Combination with ~~Lancaster Exploration Limited~~MKAR, Mkango Polska S.P.Z.O.O., MKA BVI, and Mkango ServiceCo UK Limited.

Put Option Buyout Letter Agreement

On June 2, 2025, ~~Lancaster~~MKAR agreed to issue and sell a convertible promissory note to an affiliate of the Company’s Chairman (the “Investor”) in connection with the Proposed Business Combination with a principal amount of $500,000 (the “BCA Note”), as described in the Note Purchase Agreement in the Company’s Form 8-K filed with the SEC on June 3, 2025.

Results of Operations and Known Trends or Future Events

We have neither engaged in any operations nor generated any revenues to date. Our only activities since inception have been organizational activities, those necessary to prepare for the Initial Public Offering and identifying a target company for our initial business combination. We do not expect to generate any operating revenues until after completion of our initial business combination. We generate non-operating income in the form of interest income on cash and cash equivalents held in the trust account. We incur expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses.

For the three months ended September 30, 2025, we had net loss of $187,187. We incurred $281,409 of operating costs partially offset by a change in fair value of warrant liabilities of $35,533 and trust dividend income of $58,689. 22

For the three months ended ~~September~~March 3031, ~~2024~~2026, we had a net loss of $~~161~~1,~~227~~029,307. ~~driven~~We byincurred $~~260~~1,~~603~~069,505 of operating costs and ~~non-redemption~~$10,362 ~~agreement expense~~in ofloan ~~$75,341,~~extension agreement expense partially offset by ~~income~~a ~~in our~~ trust ~~account~~dividend income of $~~174~~50,~~717~~560.

For the ~~nine~~three months ended ~~September~~March 3031, 2025, we we had net loss of $2712,~~103,992~~127. We incurred $2772,~~059,665~~793 of operating costs ~~and non-redemption agreement expense of $223~~,~~138~~ partially offset by ~~a change in fair value of warrant liabilities of $14 and~~ trust dividend income of $~~178~~60,~~797~~666.

For the nine months ended September 30, 2024, we had a net loss of $259,248 driven by non-redemption agreement expense of $451,322 and $688,859 of operating costs partially offset by income in our trust account for $880,933.

Liquidity, Capital Resources and Going Concern

On February 11, 2021, we consummated our IPO of 27,600,000 Units, at a price of $10.00 per Unit, which included the exercise of the underwriters’ option to purchase an additional 3,600,000 Units at the IPO price to cover over-allotments. The Units were sold, generating gross proceeds of $276,000,000. Substantially concurrently with the closing of the IPO, we completed the private sale of 5,013,333 Private Placement Warrants to Crown PropTech Sponsor and the Anchor Investor at a purchase price of $1.50 per Private Placement Warrant, generating gross proceeds to the Company of $7,520,000.

Following the IPO, the sale of the Private Placement Warrants, and the underwriters’ election to fully exercise their over-allotment option, a total of $276,000,000 was placed in the Trust Account at J.P. Morgan Chase Bank, N.A., maintained by Continental Stock Transfer & Trust Company, acting as trustee, and we had $1,919,091 of cash held outside of the Trust Account, after payment of costs related to the IPO, and available for working capital purposes. We incurred $16,505,915 in transaction costs, including $5,520,000 of underwriting fees, $9,660,000 of deferred underwriting fees, $795,825 of excess fair value of the Anchor Investor shares and $530,090 of other offering costs. In December 2022, the underwriters agreed to waive their right to receive any additional deferred underwriting discount.

For the ~~nine~~three months ended ~~September~~March 3031, ~~2025~~2026, ~~cash~~ cash used in operating activities was $~~498~~629,~~776~~334, resulting from a net loss of $21,~~103~~029,~~992~~307 which was impacted ~~non-redemption~~trust ~~agreement~~dividend ~~expense of~~income ~~$223,138 change in fair value~~ of ~~warrant liabilities of~~ $1450,560, loan ~~trust~~extension ~~dividend~~agreement ~~income~~expense of $~~178~~10,~~797~~362 and changes in operating assets and liabilities of $1440,~~560,889~~171.

For the ~~nine~~three months ended ~~September~~March 3031, ~~2024~~2025, cash used in operating activities was $~~263~~86,~~483~~142, resulting from a net loss of $~~259~~712,~~248~~127 which was impacted ~~by non-redemption agreement expense of $451,322,~~ trust dividend income of $~~880~~60,~~933~~666 and changes in operating assets and liabilities of $~~425~~686,~~376~~651.

26As of March 31, 2026 and December 31, 2025, we had cash outside the trust account of $425 available for working capital needs and working capital deficits of $5,737,213 and $5,297,042, respectively. All remaining cash held in the trust account is generally unavailable for our use, prior to an initial business combination, and is restricted for use either in a business combination or to redeem ordinary shares. As of March 31, 2026 and December 31, 2025, none of the amount in the trust account was available to be withdrawn as described above.

AsThrough ofMarch ~~September 30~~31, ~~2025 and December 31~~2026, ~~2024,~~ weour ~~had~~liquidity ~~cash~~needs ~~outside~~were satisfied ~~the~~through ~~trust~~receipt ~~account~~ of $~~425~~25,000 ~~available~~from ~~for~~the ~~working~~sale ~~capital~~of ~~needs~~the ~~and~~Founder ~~working capital deficits of $4~~Shares,~~917,295~~ ~~and $2,977,586,~~the ~~respectively. All~~ remaining ~~cash~~net ~~held~~proceeds infrom the ~~trust~~Initial ~~account~~Public isOffering, the ~~generally~~sale ~~unavailable~~of ~~for~~Private ~~our~~Placement ~~use~~Warrants, ~~prior~~the toPromissory anNote ~~initial business combination,~~ and isthe ~~restricted~~Convertible ~~for~~Note ~~use~~(as ~~either~~defined inbelow) aand ~~business~~capital ~~combination~~contributions orfrom the toSponsors ~~redeem ordinary shares. As~~ of ~~September 30~~$2, ~~2025 and December 31~~007, ~~2024, none of the amount in the trust account was available to be withdrawn as described above~~967.

Through September 30, 2025, our liquidity needs were satisfied through receipt of $25,000 from the sale of the Founder Shares, the remaining net proceeds from the Initial Public Offering, the sale of Private Placement Warrants, the Promissory Note and the Convertible Note (as defined below) and capital contributions from the Sponsors of $793,374.

On November 30, 2021, the Company entered into a convertible note with Richard Chera, its former Chief Executive Officer and director, pursuant to which Mr. Chera agreed to loan the Company up to an aggregate principal amount of $1,500,000 (the “Convertible Note”). The Convertible Note was non-interest bearing and due on the earlier of: (i) 12 months from the date thereof or (ii) the date on which the Company consummates a Business Combination. If the Company does not consummate a Business Combination, the Company may use a portion of any funds held outside the Trust Account to repay the Convertible Note; however, no proceeds from the Trust Account may be used for such repayment if the Company does not consummate the Business Combination. Up to $1,500,000 of the Convertible Note may be converted into warrants at a price of $1.50 per warrant at the option of Mr. Chera (the “Conversion Right”). The warrants would be identical to the Private Placement Warrants.

As of September 30, 2025, CIIG has advanced funds to and paid expenses on behalf of the Company in the amount of $539,934. Of these funds, $419,978 is reported as due to related parties on the balance sheet. These borrowings are non-interest bearing. The remaining $119,956 is reported on the statements of changes in shareholders’ deficit as a capital contribution from Sponsor.23

~~Borrowing~~On ~~under~~February 10, 2026, the Second A&R Note was ~~and~~amended to be due on the ~~advances from~~earlier ~~CIIG~~of: ~~are~~(i) ~~reported~~December 31, 2026; (ii) the date on which the ~~balance~~Company ~~sheets~~consummates asa ~~due~~Business toCombination; or ~~related~~(iii) ~~parties~~the effective date of a liquidation of the Company (“Third A&R Note”). AtIn ~~September~~connection ~~30,~~with ~~2025~~the ~~and~~execution ~~December~~of ~~31,~~the Third ~~2024~~A&R Note, CIIG Management III LLC has agreed to transfer additional Class B Ordinary Shares to an unaffiliated third party in an amount equal to the ~~Company~~product ~~reported~~of the number of months from February 2026 until the date on which SPAC consummates a Business Combination $1and 2,~~567,897~~500 and ~~$1,189,077,~~subject ~~respectively,~~to the same transfer restrictions that are imposed on ~~the~~CIIG ~~balance~~Management ~~sheets~~III LLC.

~~The Company~~For ~~has~~the ~~incurred~~three ~~and~~months ~~expects~~ended toMarch ~~continue~~31, to2026, ~~incur~~CIIG has ~~significant~~paid ~~costs~~expenses inon ~~pursuit~~behalf of ~~its~~the ~~financing and acquisition plans. The~~ Company ~~lacks~~ in the ~~financial~~amount ~~resources it needs to sustain operations for a reasonable period~~ of ~~time~~$629,334 ~~which~~and is ~~considered~~reported toon ~~be one year from~~ the ~~issuance~~statements ~~date~~ of ~~the~~changes ~~financial~~in ~~statements~~shareholders’ deficit ~~are~~as ~~issued.~~a ~~Although~~capital nocontribution ~~formal~~from ~~agreement exists, the Sponsors are committed to extend loans as needed~~Sponsor.

Borrowing under the A&R Note and the advances from CIIG are reported on the balance sheets as due to related parties. At March 31, 2026 and December 31, 2025, the Company reported $1,592,586 on the balance sheets.

Commitments and Contingencies

Registration Rights

The holders of the Founder Shares, Private Placement Warrants and any warrants that may be issued upon conversion of working capital loans (and any ordinary shares issuable upon the exercise of the Private Placement Warrants or warrants issued upon conversion of the working capital loans and upon conversion of the Founder Shares) are entitled to registration rights pursuant to a registration rights agreement signed prior to the effective date of the IPO requiring the Company to register such securities for resale. The holders of these securities will be entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggyback” registration rights with respect to registration statements filed subsequent to the completion of a business combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

Advisory Service Agreements

We may enlist various entities as capital market advisors to assist in the identification and consummation of an initial business combination. Fees for such services will be payable only upon consummation of an initial business combination by us.

As discussed above, on June 1, 2025, the Company engaged Jett Capital as financial advisor to advise the Company on their proposed Business Combination with ~~Lancaster Exploration Limited~~MKAR, Mkango Polska S.P.Z.O.O., MKA BVI, and Mkango ServiceCo UK Limited. Except for $100,000 due upon execution of the agreement, fees for such services will be payable only upon consummation of an initial business combination by us.

A&R Note

On November 30, 2021, we entered into a convertible promissory note with Richard Chera, our former Chief Executive Officer and Director, pursuant to which Mr. Chera agreed to loan us up to an aggregate principal amount of $1,500,000. On May 31, 2023, the promissory note was amended and restated in the aggregate principal amount of up to $1,000,000. On March 28, 2025, the A&R Note in the aggregate principal amount of up to $1,000,000 was amended to be due on the earlier of: (i) February 11, 2026; (ii) the date on which the Company consummates a Business Combination; or (iii) the effective date of a liquidation of the Company. See “Liquidity and Capital Resources.”

On February 10, 2026, the Second A&R Note was amended to replace “February 11, 2026” with December 31, 2026 (the “Third A&R Note”). In connection with the execution of the Third A&R Note, CIIG Management III LLC has agreed to transfer additional CPTK Class B Ordinary Shares to an unaffiliated third party in an amount equal to the product of the number of months from February 2026 until the date on which SPAC consummates a Business Combination and 2,500 and subject to the same transfer restrictions that are imposed on CIIG Management III LLC.

Contractual Obligation

We do not have any long-term debt obligations, capital lease obligations, operating lease obligations, purchase obligations or long-term liabilities other than described above.

Critical Accounting Estimates

The preparation of these ~~financial~~unaudited condensed financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates. We have not identified any critical accounting estimates other than the non-redemption agreement discussed below.

Significant Accounting Policies

Non-Redemption Agreements

In 2024, the Company and CIIG entered into certain non-redemption agreements and assignments of economic interests (the “Non-Redemption Agreements”) with certain investors (the “Non-Redeeming Investors”). The Non-Redemption Agreements provide for the assignment of economic interest of Class B ordinary shares held by CIIG to the Non-Redeeming Investors in exchange for such Non-Redeeming Investors agreeing to hold and not redeem Class A ordinary shares at the Extraordinary General Meetings. Pursuant to the Non-Redemption Agreements, CIIG has agreed to transfer to such Non-Redeeming Investors Class A ordinary shares upon conversion of the Class B ordinary shares in connection with the consummation of an initial Business Combination. For the ~~three~~year ~~and nine months~~ ended ~~September 30~~December 31, 2024, the Company estimated the aggregate fair value of the Class B ordinary shares attributable to the Non-Redeeming Investors to be $~~75,341 and $~~451,322 or $0.~~65 and $0.~~78 per share~~, respectively~~.

Beginning on May 6, 2025, and continuing until the May 9, 2025 Extraordinary General Meeting, the Company and CIIG entered into Non-Redemption Agreements with the Non-Redeeming Investors. The Non-Redemption Agreements provide for the assignment of economic interest of an aggregate of 115,287 Class B ordinary shares ~~held~~ held by CIIG to the Non-Redeeming Investors in exchange for such Non-Redeeming Investors agreeing to hold and not redeem an aggregate of 461,146 Class A ordinary shares at the May 9, 2025 Extraordinary General Meeting. Pursuant to the Non-Redemption Agreements, CIIG has agreed to transfer to such Non-Redeeming Investors an aggregate of 115,287 Class A ordinary shares upon conversion of the Class B ordinary shares in connection with the consummation of an initial Business Combination. For the three ~~and nine~~ months ended ~~September 30~~March 31, ~~2025~~2026, the Company estimated the aggregate fair value of the 115,287 Class B ordinary shares attributable to the Non-Redeeming Investors to be $~~0 and $~~223,138 or $~~0 and $~~1.94 per share~~, respectively~~.

We utilized a model to determine the fair value of the Non-Redemption Agreements using observable and unobservable assumptions about current and anticipated events. Significant assumptions include the probability and timing of consummating a business combination. Significant variations in these assumptions could have a material impact to the unaudited condensed financial statements.

Loan Extension Agreement

The loan extension agreement provides for us to transfer shares of the company to a third party under certain conditions.

The Company complies with Staff Accounting Bulletin Topic 5T and recognizes a capital contribution, as the potential transfer of these shares is a benefit to the Company.

Recent Accounting Standards

Off-Balance Sheet Arrangements

As of ~~September~~March 3031, ~~2025~~2026, we did not have any off-balance sheet arrangements as defined in Item 303(a)(4)(ii) of Regulation S-K.

JOBS Act

The Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”) contains provisions that, among other things, relax certain reporting requirements for qualifying public companies. We qualify as an “emerging growth company” and under the JOBS Act are allowed to comply with new or revised accounting pronouncements based on the effective date for private (not publicly traded) companies. We are electing to delay the adoption of new or revised accounting standards, and as a result, we may not comply with new or revised accounting standards on the relevant dates on which adoption of such standards is required for non-emerging growth companies. As a result, the financial statements may not be comparable to companies that comply with new or revised accounting pronouncements as of public company effective dates.

Additionally, we are in the process of evaluating the benefits of relying on the other reduced reporting requirements provided by the JOBS Act. Subject to certain conditions set forth in the JOBS Act, if, as an “emerging growth company,” we choose to rely on such exemptions we may not be required to, among other things, (i) provide an auditor’s attestation report on our system of internal controls over financial reporting pursuant to Section 404, (ii) provide all of the compensation disclosure that may be required of non-emerging growth public companies under the Dodd-Frank Wall Street Reform and Consumer Protection Act, (iii) comply with any requirement that may be adopted by the PCAOB regarding mandatory audit firm rotation or a supplement to the auditor’s report providing additional information about the audit and the financial statements (auditor discussion and analysis) and (iv) disclose certain executive compensation related items such as the correlation between executive compensation and performance and comparisons of the chief executive officer’s compensation to median employee compensation. These exemptions will apply for a period of five years following the completion of our IPO or until we are no longer an “emerging growth company,” whichever is earlier.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information otherwise required under this Item.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

As required by Rules 13a-15 and 15d-15 under the Exchange Act, our Chief Executive Officer carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as of ~~September~~March 3031, ~~2025~~2026. Based upon their evaluation, our Chief Executive Officer concluded that our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) were not effective, due solely to the material weakness in our internal control over financial reporting related to the Company’s accounting for complex financial instruments and review procedures around key reconciliations including accruals and payables. As a result, we performed additional analysis as deemed necessary to ensure that our financial statements were prepared in accordance with GAAP. Accordingly, management believes that the financial statements included in this Quarterly Report present fairly in all material respects our unaudited condensed financial position, results of operations and unaudited condensed cash flows for the period presented.

Management has identified a material weakness in internal controls related to the accounting for complex financial instruments and review procedures around key reconciliations including accruals and payables. While we have processes to identify and appropriately apply applicable accounting requirements, we plan to continue to enhance our system of evaluating and implementing the accounting standards that apply to our financial statements, including through enhanced analyses by our personnel and third-party professionals with whom we consult regarding complex accounting applications. The elements of our remediation plan can only be accomplished over time, and we can offer no assurance that these initiatives will ultimately have the intended effects.

Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is accumulated and communicated to our management, including our Chief Executive Officer, to allow timely decisions regarding required disclosure.

Changes in Internal Control over Financial Reporting

There was no change in our internal control over financial reporting that occurred during the three and nine months ended ~~September~~March 3031, ~~2025~~2026, covered by this Quarterly Report on Form 10-Q that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

3027

PART II – OTHER INFORMATION

Item 1. Legal Proceedings

From time to time, we may be subject to legal proceedings and claims that arise in the search for a potential target business. We are not currently aware of any such proceedings or claims that we believe will have, individually or in the aggregate, a material adverse effect on our business, financial condition or results of operations.

Item 1A. Risk Factors

Factors that could cause our actual results to differ materially from those in this Quarterly Report on Form 10-Q include the risks described in our Annual Report on Form 10-K for the year ended December 31, ~~2024~~2025 filed with the SEC on ~~December~~March 331, ~~2025~~2026. Any of these factors could result in a significant or material adverse effect on our business, financial condition or future results. Additional risks and uncertainties not presently known to us or that we currently deem immaterial may also impair our business or results of operations.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

There were no unregistered sales of our equity securities during the period covered by this Quarterly Report which were not previously reported in a Current Report on Form 8-K.

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine Safety Disclosures

Not applicable.

Item 5. Other Information

Rule 10b5-1 Trading Plans

During the quarter ended ~~September~~March 3031, ~~2025~~2026, none of the Company’s directors or officers adopted or terminated any contract, instruction or written plan for the purchase or sale of Company securities that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) or any “non-Rule 10b5-1 trading arrangement.”

3128

Item 6. Exhibits.

Exhibit Number		Description
2.1†		Amendment No. 1 to Business Combination Agreement, dated as of ~~July~~February 213, ~~2025~~2026, by and among CPTK, ~~Lancaster~~and ~~Exploration Limited,~~ Mkango ~~Polska~~Rare ~~S.P.Z.O.O.,~~Earths ~~MKA Exploration~~ Limited, ~~Mkango ServiceCo UK Limited and Mkango~~ (~~Cayman) Limited (~~incorporated by reference to Exhibit 2.1 to the Current Report on Form 8-K filed on ~~July~~February 310, ~~2025~~2026 (file no. 001-40017).
10.1		Shareholder Support Agreement, dated July 2, 2025, by and among CPTK, Mkango Resources Ltd., Lancaster Exploration Limited, Mkango ServiceCo UK Limited and MKA Exploration Limited (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed on July 3, 2025 (file no. 001-40017).
3.1		Sixth Amended and Restated Memorandum and Articles of Association of Crown PropTech Acquisitions (incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K filed on March 9, 2026 (file no. 001-40017)
10.2		Sponsor Support Agreement, dated as of July 2, 2025, by and among CPTK, CIIG Management III LLC, the investor parties thereto, Lancaster Exploration Limited, Mkango Polska s.p. Z.o.o., Mkango ServiceCo UK Limited and MKA Exploration Limited (incorporated by reference to Exhibit 10.2 to the Current Report on Form 8-K filed on July 3, 2025 (file no. 001-40017).
10.1		Third Amended and Restated Promissory Note, dated February 10, 2026, issued by CPTK to Richard Chera (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed on February 10, 2026 (file no. 001-40017).
10.2		Form of Non-Redemption Agreement and Assignment of Economic Interest (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed on March 5, 2026 (file no. 001-40017).
31.1*		Certification of Chief Executive Officer (Principal Executive Officer and Principal Financial Officer) Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1**		Certification of Chief Executive Officer (Principal Executive Officer and Principal Financial Officer) Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.SCH		Inline XBRL Taxonomy Extension Schema Document
101.CAL		Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF		Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB		Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE		Inline XBRL Taxonomy Extension Presentation Linkbase Document
104		Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)

*	Filed herewith.

**	These certifications are furnished to the SEC pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and are deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.

†	Schedules omitted pursuant to Item 601(b)(2) of Regulation S-K. Registrant agrees to furnish supplementally a copy of any omitted schedule to the Securities and Exchange Commission upon request.

3229

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	CROWN PROPTECH ACQUISITIONS
Date: December 23, 2025	By:	/s/ Michael Minnick
Date: May 18, 2026	By:	/s/ Michael Minnick
	Name:	Michael Minnick
	Title:	Chief Executive Officer
		(Principal Executive Officer)

3330

00-0000000 NONE http://fasb.org/srt/2025#ChiefExecutiveOfficerMember 0001827899 false Q3 --12-31 0001827899 2025-01-01 2025-09-30 0001827899 us-gaap:CommonClassAMember 2025-12-23 0001827899 us-gaap:CommonClassBMember 2025-12-23 0001827899 2025-09-30 0001827899 2024-12-31 0001827899 us-gaap:RelatedPartyMember 2025-09-30 0001827899 us-gaap:RelatedPartyMember 2024-12-31 0001827899 cptkw:CommonClassASubjectToRedemptionMember 2025-09-30 0001827899 cptkw:CommonClassASubjectToRedemptionMember 2024-12-31 0001827899 us-gaap:CommonClassAMember 2025-09-30 0001827899 us-gaap:CommonClassAMember 2024-12-31 0001827899 us-gaap:CommonClassBMember 2025-09-30 0001827899 us-gaap:CommonClassBMember 2024-12-31 0001827899 2025-07-01 2025-09-30 0001827899 2024-07-01 2024-09-30 0001827899 2024-01-01 2024-09-30 0001827899 cptkw:RedeemableSharesMember 2025-07-01 2025-09-30 0001827899 cptkw:RedeemableSharesMember 2024-07-01 2024-09-30 0001827899 cptkw:RedeemableSharesMember 2025-01-01 2025-09-30 0001827899 cptkw:RedeemableSharesMember 2024-01-01 2024-09-30 0001827899 cptkw:NonRedeemableSharesMember 2025-07-01 2025-09-30 0001827899 cptkw:NonRedeemableSharesMember 2024-07-01 2024-09-30 0001827899 cptkw:NonRedeemableSharesMember 2025-01-01 2025-09-30 0001827899 cptkw:NonRedeemableSharesMember 2024-01-01 2024-09-30 0001827899 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2024-12-31 0001827899 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001827899 us-gaap:RetainedEarningsMember 2024-12-31 0001827899 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2025-01-01 2025-03-31 0001827899 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-03-31 0001827899 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0001827899 2025-01-01 2025-03-31 0001827899 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2025-03-31 0001827899 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0001827899 us-gaap:RetainedEarningsMember 2025-03-31 0001827899 2025-03-31 0001827899 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2025-04-01 2025-06-30 0001827899 us-gaap:AdditionalPaidInCapitalMember 2025-04-01 2025-06-30 0001827899 us-gaap:RetainedEarningsMember 2025-04-01 2025-06-30 0001827899 2025-04-01 2025-06-30 0001827899 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2025-06-30 0001827899 us-gaap:AdditionalPaidInCapitalMember 2025-06-30 0001827899 us-gaap:RetainedEarningsMember 2025-06-30 0001827899 2025-06-30 0001827899 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2025-07-01 2025-09-30 0001827899 us-gaap:AdditionalPaidInCapitalMember 2025-07-01 2025-09-30 0001827899 us-gaap:RetainedEarningsMember 2025-07-01 2025-09-30 0001827899 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2025-09-30 0001827899 us-gaap:AdditionalPaidInCapitalMember 2025-09-30 0001827899 us-gaap:RetainedEarningsMember 2025-09-30 0001827899 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2023-12-31 0001827899 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001827899 us-gaap:RetainedEarningsMember 2023-12-31 0001827899 2023-12-31 0001827899 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001827899 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0001827899 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0001827899 2024-01-01 2024-03-31 0001827899 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2024-03-31 0001827899 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001827899 us-gaap:RetainedEarningsMember 2024-03-31 0001827899 2024-03-31 0001827899 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2024-04-01 2024-06-30 0001827899 us-gaap:AdditionalPaidInCapitalMember 2024-04-01 2024-06-30 0001827899 us-gaap:RetainedEarningsMember 2024-04-01 2024-06-30 0001827899 2024-04-01 2024-06-30 0001827899 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2024-06-30 0001827899 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 0001827899 us-gaap:RetainedEarningsMember 2024-06-30 0001827899 2024-06-30 0001827899 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2024-07-01 2024-09-30 0001827899 us-gaap:AdditionalPaidInCapitalMember 2024-07-01 2024-09-30 0001827899 us-gaap:RetainedEarningsMember 2024-07-01 2024-09-30 0001827899 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2024-09-30 0001827899 us-gaap:AdditionalPaidInCapitalMember 2024-09-30 0001827899 us-gaap:RetainedEarningsMember 2024-09-30 0001827899 2024-09-30 0001827899 us-gaap:IPOMember 2021-02-11 2021-02-11 0001827899 us-gaap:IPOMember 2025-09-30 0001827899 us-gaap:CommonClassBMember cptkw:NonRedemptionAgreementsMember 2024-02-09 2024-02-09 0001827899 cptkw:NonRedemptionAgreementsMember 2024-02-09 0001827899 us-gaap:CommonClassAMember 2024-02-09 2024-02-09 0001827899 us-gaap:CommonClassAMember 2024-02-09 0001827899 2024-02-09 0001827899 us-gaap:CommonClassAMember 2024-08-09 2024-08-09 0001827899 cptkw:NonRedemptionAgreementsMember 2024-08-09 0001827899 us-gaap:CommonClassAMember 2024-08-09 0001827899 us-gaap:CommonClassBMember 2024-08-09 0001827899 us-gaap:CommonClassAMember 2025-05-09 2025-05-09 0001827899 cptkw:NonRedemptionAgreementsMember 2025-05-09 0001827899 us-gaap:CommonClassAMember 2025-05-09 0001827899 us-gaap:CommonClassBMember cptkw:NonRedemptionAgreementsMember 2025-05-09 2025-05-09 0001827899 us-gaap:CommonClassAMember 2021-02-11 2021-02-11 0001827899 us-gaap:CommonClassAMember 2021-02-11 0001827899 us-gaap:WarrantMember 2025-09-30 0001827899 us-gaap:PrivatePlacementMember 2025-09-30 0001827899 srt:ChiefExecutiveOfficerMember 2021-11-30 0001827899 us-gaap:WarrantMember 2022-12-31 0001827899 srt:ChiefExecutiveOfficerMember 2022-12-31 0001827899 srt:ChiefExecutiveOfficerMember us-gaap:WarrantMember 2022-12-31 0001827899 us-gaap:CommonClassBMember cptkw:NonRedemptionAgreementsMember 2024-02-29 2024-02-29 0001827899 us-gaap:CommonClassAMember 2024-02-29 2024-02-29 0001827899 us-gaap:CommonClassBMember cptkw:NonRedemptionAgreementsMember 2024-02-29 0001827899 us-gaap:CommonClassBMember cptkw:NonRedemptionAgreementsMember 2024-08-08 2024-08-08 0001827899 us-gaap:CommonClassAMember cptkw:NonRedemptionAgreementsMember 2024-08-08 2024-08-08 0001827899 us-gaap:CommonClassAMember cptkw:NonRedemptionAgreementsMember 2024-08-08 0001827899 us-gaap:CommonClassBMember cptkw:NonRedemptionAgreementsMember 2025-01-01 2025-09-30 0001827899 us-gaap:CommonClassBMember cptkw:NonRedemptionAgreementsMember 2025-09-30 0001827899 us-gaap:CommonClassBMember cptkw:NonRedemptionAgreementsMember 2025-05-06 0001827899 us-gaap:CommonClassAMember 2025-05-06 2025-05-09 0001827899 2025-05-09 0001827899 us-gaap:CommonClassBMember 2025-05-09 0001827899 cptkw:OrdinarySharesSubjectToPossibleRedemptionMember 2023-12-31 0001827899 cptkw:OrdinarySharesSubjectToPossibleRedemptionMember 2024-01-01 2024-12-31 0001827899 cptkw:OrdinarySharesSubjectToPossibleRedemptionMember 2024-12-31 0001827899 cptkw:OrdinarySharesSubjectToPossibleRedemptionMember 2025-01-01 2025-03-31 0001827899 cptkw:OrdinarySharesSubjectToPossibleRedemptionMember 2025-03-31 0001827899 cptkw:OrdinarySharesSubjectToPossibleRedemptionMember 2025-04-01 2025-06-30 0001827899 cptkw:OrdinarySharesSubjectToPossibleRedemptionMember 2025-06-30 0001827899 cptkw:OrdinarySharesSubjectToPossibleRedemptionMember 2025-07-01 2025-09-30 0001827899 cptkw:OrdinarySharesSubjectToPossibleRedemptionMember 2025-09-30 0001827899 cptkw:RedeemableClassAMember 2025-07-01 2025-09-30 0001827899 cptkw:NonredeemableClassBMember 2025-07-01 2025-09-30 0001827899 cptkw:RedeemableClassAMember 2024-07-01 2024-09-30 0001827899 cptkw:NonredeemableClassBMember 2024-07-01 2024-09-30 0001827899 cptkw:RedeemableClassAMember 2025-01-01 2025-09-30 0001827899 cptkw:NonredeemableClassBMember 2025-01-01 2025-09-30 0001827899 cptkw:RedeemableClassAMember 2024-01-01 2024-09-30 0001827899 cptkw:NonredeemableClassBMember 2024-01-01 2024-09-30 0001827899 us-gaap:IPOMember 2025-01-01 2025-09-30 0001827899 us-gaap:CommonClassAMember us-gaap:IPOMember 2025-01-01 2025-09-30 0001827899 cptkw:PublicWarrantMember us-gaap:IPOMember 2025-01-01 2025-09-30 0001827899 us-gaap:CommonClassAMember us-gaap:IPOMember 2025-09-30 0001827899 cptkw:PublicWarrantMember us-gaap:CommonClassAMember us-gaap:IPOMember 2025-09-30 0001827899 cptkw:PublicWarrantMember us-gaap:CommonClassAMember us-gaap:IPOMember 2025-01-01 2025-09-30 0001827899 cptkw:PrivatePlacementWarrantsMember 2025-09-30 0001827899 cptkw:PrivatePlacementWarrantsMember 2025-01-01 2025-09-30 0001827899 cptkw:PrivatePlacementWarrantsMember us-gaap:CommonClassAMember 2025-09-30 0001827899 cptkw:FounderShareMember cptkw:SponsorMember us-gaap:CommonClassBMember 2020-10-13 2020-10-13 0001827899 us-gaap:CommonClassBMember 2021-02-09 2021-02-09 0001827899 cptkw:FounderShareMember us-gaap:CommonClassBMember 2021-02-09 0001827899 cptkw:FounderShareMember 2021-02-11 2021-02-11 0001827899 cptkw:FounderShareMember 2021-02-01 2021-02-28 0001827899 cptkw:SponsorMember 2021-02-01 2021-02-28 0001827899 us-gaap:CommonClassBMember 2023-01-17 2023-01-17 0001827899 cptkw:PrivatePlacementWarrantsMember us-gaap:CommonClassAMember 2023-01-17 2023-01-17 0001827899 us-gaap:CommonClassBMember cptkw:PrivatePlacementWarrantsMember 2023-01-17 2023-01-17 0001827899 srt:MinimumMember us-gaap:CommonClassAMember 2025-01-01 2025-09-30 0001827899 srt:MaximumMember us-gaap:CommonClassAMember 2025-01-01 2025-09-30 0001827899 us-gaap:CommonClassAMember 2025-01-01 2025-09-30 0001827899 cptkw:BusinessCombinationMember 2025-09-30 0001827899 cptkw:BusinessCombinationMember us-gaap:WarrantMember 2025-09-30 0001827899 srt:ChiefExecutiveOfficerMember cptkw:ConvertibleNoteMember us-gaap:RelatedPartyMember 2021-11-30 0001827899 srt:ChiefExecutiveOfficerMember 2021-11-30 2021-11-30 0001827899 srt:ChiefExecutiveOfficerMember us-gaap:WarrantMember 2021-11-30 2021-11-30 0001827899 cptkw:ConvertibleNoteMember 2023-05-31 2023-05-31 0001827899 cptkw:ConvertibleNoteMember 2025-03-28 2025-03-28 0001827899 cptkw:CIIGMember 2025-09-30 2025-09-30 0001827899 us-gaap:RelatedPartyMember 2025-09-30 2025-09-30 0001827899 2025-09-30 2025-09-30 0001827899 cptkw:ConvertiblePromissoryNoteMember cptkw:LancasterMember 2025-06-02 0001827899 cptkw:JettCapitalMember 2025-01-01 2025-09-30 0001827899 cptkw:PublicWarrantsMember 2025-01-01 2025-09-30 0001827899 cptkw:PublicWarrantsMember 2025-09-30 0001827899 us-gaap:WarrantMember us-gaap:CommonClassAMember 2025-09-30 0001827899 srt:MinimumMember cptkw:PublicWarrantsMember 2025-01-01 2025-09-30 0001827899 srt:MaximumMember cptkw:PublicWarrantsMember 2025-01-01 2025-09-30 0001827899 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2025-09-30 0001827899 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2025-09-30 0001827899 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2025-09-30 0001827899 cptkw:PublicWarrantsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2025-09-30 0001827899 cptkw:PublicWarrantsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2025-09-30 0001827899 cptkw:PublicWarrantsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2025-09-30 0001827899 cptkw:PrivateWarrantsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2025-09-30 0001827899 cptkw:PrivateWarrantsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2025-09-30 0001827899 cptkw:PrivateWarrantsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2025-09-30 0001827899 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2024-12-31 0001827899 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2024-12-31 0001827899 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2024-12-31 0001827899 cptkw:PublicWarrantsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2024-12-31 0001827899 cptkw:PublicWarrantsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2024-12-31 0001827899 cptkw:PublicWarrantsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2024-12-31 0001827899 cptkw:PrivateWarrantsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2024-12-31 0001827899 cptkw:PrivateWarrantsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2024-12-31 0001827899 cptkw:PrivateWarrantsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2024-12-31 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure

Filing Compare · Crown PropTech Acquisitions